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The study of the health and disease of populations after migration has a long tradition 
in epidemiology. The communities with birth or ancestral origins in the Indian 
subcontinent - now called South Asian - are a vital part of the social and economic 
fabric of modern, multicultural Britain. It is no surprise that, when exposed to a new 
environment and way of life, the health experience of South Asians is different from 
that in their countries of origin. Their greater susceptibility to coronary heart disease 
is an important example, and was the subject of this ground-breaking symposium. 
 
Coronary heart disease remains one of the leading killers in our country. Exploring 
the reasons for its even greater impact in South Asian communities living in Britain is 
an important area for research. Assessing the evidence to enable an effective public 
health response is a major challenge. 
 
The symposium brought together leading researchers and thinkers in this field. They 
are to be congratulated for the quality of their contributions and, more than this, for 
their commitment to finding solutions to the problem of coronary heart disease in the 
South Asian communities living in Britain. 
 
The publication will bring this important issue to a much wider audience and we 
believe enable many others to come forward to help advance understanding of the 
problem and to take action to combat it. 
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on behalf of the Department of Health 
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Coronary heart disease (CHD) poses a massive challenge globally. Over the last 50 
years there has been an explosion of research from bench to bedside to population, to 
explore the multifactorial aetiology of CHD. One important discovery is that the UK 
population of South Asian origin is at significantly greater mortality risk from CHD 
than the population as a whole. Despite significant research the exact explanation(s) 
for the increased risk of South Asians is undetermined. In December 2001, The South 
Asian Health Foundation, with the support of the British Heart Foundation and the 
Department of Health hosted its first UK symposium on ‘The epidemic of coronary 
heart disease in South Asian populations: causes and consequences.’ Leading 
researchers in the field of ethnicity and coronary disease were invited to present their 
research and share knowledge to help in the management of this epidemic. This book 
summarises and updates the work from the symposium, with the aim to disseminate 
this vital information. We are aware that this field is advancing rapidly but we hope, 
on behalf of The South Asian Health Foundation, that this book will highlight 
important and relevant issues to all involved in the management of South Asian 
patients with CHD. We would like to thank all of our contributors, the British Heart 
Foundation and Department of Health for their support in publication of this book and 
last but not least, the other Patrons and Trustees of the South Asian Health Foundation 
without whom the initial symposium and ensuing publication would not have been 
possible. 
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Glossary 
_____________________________________________________________________ 
Glossary of terms relating to ethnicity and race used in this monograph are: 
 
African A person with African ancestral origins who self-identifies as 
African, but excluding South Asians. 
 
Afro-Caribbean:  A person of African ancestral origins whose family settled in 
the Caribbean before coming to Britain and who self-identifies 
as Afro-Caribbean. (See also Black.) 
 
Bangladeshi: A person whose ancestry lies in the Indian subcontinent who 
self-identifies as Bangladeshi. (See also South Asian.) 
 
Chinese: A person with ancestral origins in China, including Hong 
Kong who self-identifies as Chinese. 
 
Ethnicity1:  The social group a person belongs to, and both identifies with 
and is identified with, as a result of a mix of cultural and other 
factors including language, diet, religion, ancestry, and race.  
See also race. 
 
European Effectively this is a synonym for White (see below). 
 
Indian: A person whose ancestry lies in the Indian sub-continent who 
identifies as Indian (see, South Asian).  (Major changes to 
India's geographical boundaries took place in 1947). 
 
Pakistani: A person whose ancestry lies in the Indian subcontinent who 
identifies as Pakistani (see South Asian). 
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Race:  The group a person belongs to as a result of a mix of physical 
features (e.g. skin colour, hair texture), ancestry and 
geographical origins, as identified by others or, increasingly, 
as self identified.  The importance of social factors in the 
creation and perpetuation of racial categories has led to the 
concept broadening to include social and political heritage, 
making its usage similar to ethnicity.  Race and ethnicity are 
increasingly used as synonyms.   See also ethnicity. 
 
South Asian:  A person whose ancestry is in the countries of the Indian sub-
continent, including India, Pakistan, Bangladesh and Sri 
Lanka. (See also, Indian, Pakistani, Bangladeshi). 
 
White: The term usually used to describe people with European 
ancestral origins who identify as white (sometimes called 
European, Caucasian or Caucasoid). The word is capitalised to 




1The concepts of race and ethnicity are so intertwined that consideration of one 
necessarily requires consideration of the other.  In this proposal the term ethnicity is 
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Coronary heart disease in South Asians: 
the scale of the problem and the 
challenge 
 




In the 1950's and early 1960's, there emerged a gradual awareness that people with 
ancestral origins in the Indian subcontinent (henceforth called South Asians) are 
highly susceptible to cardiovascular diseases after migration to urban environments.  
Adelstein reported that in South Africa mortality rates for cardiovascular disease in 
Asian (mainly Indian) men and women, were much higher than in white men and 
women, respectively1.  Such findings have been confirmed in several countries.  In 
Britain, analysis of mortality rates around the censuses of 1971 by Marmot et al2, 
1981 by Balarajan et al3 and 1991 by Wild and McKeigue4 have shown a 15% - 60% 
excess in Indian Subcontinent born populations in comparison to the whole population 
of England and Wales.  The validity of such data will be considered below but these 
data have confirmed the view that the cardiovascular diseases are the foremost killer 
of South Asians in Britain. 
 
Coronary artery disease (CHD) is associated with industrialisation and modernisation 
of society.  CHD was uncommon in Britain in the 19th century and when it became a 
major problem, the wealthy were affected more.  Now CHD is the commonest cause 
of death and affects poorer people more.  This time-trend has not been explained 
satisfactorily.  While trends in South Asian populations remain unclear, there is some 
evidence of a decline in the absolute rates but an increase in the level of disparity in 
comparison to the whole population3, 5, a result of rapidly declining rates in the white, 
European origin populations.  The association between low social class and higher 
cardiovascular mortality and risk factors has emerged in South Asians6, 7, 8. 
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CHD is still uncommon in many countries, particularly developing countries. There is 
a paucity of information on the frequency of CHD in the Indian subcontinent and 
seemingly it is uncommon in rural areas, but is a growing problem in the cities9.  The 
epidemic in South Asians abroad forewarns of what may happen on the Indian 
Subcontinent. 
 
Most middle aged and elderly British South Asians migrated here as young adults.  
Many came from rural or semi-urban areas at a time when CHD was not a common 
problem in India.  There are two key questions about the rise of CHD in South Asians, 
first, why is the disease so unexpectedly common and, second, what can South Asians 
do to protect themselves? 
 
The cause of CHD, despite massive research, remains unclear.  There is a general 
agreement that the factors in box 1.1 increase risk of CHD either directly or indirectly.   
However, CHD occurs even without these risk factors.  The roles of stress, racism, 
inflammation, infection, specific dietary constituents such as the B vitamins and folic 
acid, and environmental pollution and many other risk factors as causes of CHD 
remain unclear. 
 
Box 1.1: Some key risk factors for CHD 
 
            Ageing 
 Male sex 
 A family history of heart disease 
 Economic deprivation 
 Smoking 
 High blood pressure 
 High concentrations of low density lipoprotein cholesterol and low 
 concentration of high density lipoprotein cholesterol 
  Diabetes 
  Failing to exercise 
 A diet which promotes atheroma 
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The term South Asian, usually used to combine Indians, Pakistanis, Bangladeshis and 
sometimes Sri Lankans, defines many ethnic groups, with distinctive regions of 
origin, languages, religions and customs 10-13.  Language impacts in obvious ways on 
clinical care and health promotion.  Religion governs important health behaviours 
such as taboos on smoking (Sikhs in particular), alcohol (Muslims in particular) and 
dietary customs.  Social customs include taboos on smoking, drinking and chewing of 
tobacco in women, the latter of which is nonetheless common in Bangladeshis.  The 
prevalence of current smoking in male South Asians in Newcastle was 33% overall, 
but 14% in Indians, and 57% in Bangladeshis; and the prevalence of weekly aerobic 
activity was 22% overall, but 33% in Indians, 19% in Pakistanis and 14% in 
Bangladeshis12.  Such heterogeneity is clearly important in CHD10-13. 
 
Since smoking is a major risk factor for CHD we would expect South Asians, Sikhs 
and Hindus in particular to have lower CHD rates than average.  However, the rates 
seem to be higher.  This observation of a high CHD rate in South Asians, in the face 
of apparently lower prevalence of smoking and other major risk factors, and in the 
light of the low rate in the Indian Subcontinent, is a public health problem, one which 
is exciting and important for researchers.  If the paradox can be explained we might 
gain more insight into the cause of CHD and refine strategies to prevent and control 
this disease in all populations.  
 
Mortality data  
 
Most data on CHD in UK ethnic groups come from mortality statistics, which have 
problems in coding cause of death, and rely upon country of birth as a marker of 
ethnicity reported by the informant, i.e., the person reporting the death.  This may 
differ from that at census where country of birth is reported by the person completing 
the form.  Mortality data are, mostly, reported by combining countries of birth e.g. 
India, Pakistan and Bangladesh as South Asian born, and many countries as Afro-
Caribbean born2-6, 10, 11.  This step has been taken in the attempt to iron out underlying 
errors in the data, and to boost numbers.  Conclusions on CHD in South Asians 
combined are being readjusted in important ways by demonstration of differences 
between Indians, Pakistanis and Bangladeshis in both disease frequency (modest but 
important)5 and coronary risk factors (substantial)12, 13.  Despite these problems with 
  3 
data quality, ethnic variations in CHD mortality in the United Kingdom are clearly 
substantial.  Mortality rates in England and Wales around the 1991 census were 40 to 
50% above average for ischaemic heart disease in South Asians in comparison to the 
total population.  A summary of published data is in reference 10. 
 
Table 1.1 (A for men, B for women) summarises a reanalysis of data for 5 years 
around the 1991 census.  Similar data are in Gill et al’s health needs assessment, 
where data on all major causes of death are available, for the age group 20 – 74 
years11.  Circulatory diseases, and specifically ischaemic heart disease, were the 
dominant causes of death in men and women11.  These SMRs in table 1.1 corroborate 
past analyses showing these diseases as 30-50% more common compared to the 
population as a whole.  The rates/100,000 for the 4 year period show that Indian men 
(3206/100,000) have much more circulatory disease than women (1469/100,000), a 
point obscured in SMR analyses.  In Pakistani men, and to a lesser extent in women, 
circulatory diseases dominate11.  In women, the SMR for ischaemic heart disease was 
only 10% higher than in the whole population. 
 
The number of deaths in Bangladeshi women was small, but neoplasms and 
circulatory diseases were the commonest cause of death11.  In women, CHD rates 
were relatively low in comparison to the whole population (Table 1.1B).  This 
however, fits with earlier work by McKeigue (SMR for Bangladeshi women 108; 
Punjabis 206)14, and by Balarajan (age standardised rate for Bangladeshi women 49, 
for Indians 98),5 which is summarised in reference 10. 
 
One common practice is combining Indians, Pakistanis, Bangladeshis and sometimes 
Sri Lankans and East Africans too into one category, South Asians.  As Table 1.1 
shows there are similarities and dissimilarities in mortality.  Gill et al examined the 
data for Indians, Pakistanis, Bangladeshis and Sri Lankans as a single group of South 
Asians together and East Africans separately.  They concluded that study of such a 
South Asian group is reasonable for diabetes, but not for many other causes11.  
Overall, it is probably wise to recognise the substantial heterogeneity in these 
populations' health needs even though the study of the separate groups poses 
additional challenges of smaller population size, and fewer deaths. 
 
  4 
Table 1.1A: Mortality rates (1989-1992) for men for ischaemic heart disease by 
country of birth and sex for ages 45-74 years (unpublished analysis Wild S and 
Bhopal R) 
Region of Birth 
 




SMR **  
(95% CI) 
India 2561 3206 141 
(136, 147) 
Pakistan 842 3062 144 
(134, 154) 
Bangladesh 366 3276 153 
(137, 169) 
China 99 1077 45 
(37, 55) 
Caribbean 816 1419 62 
(58, 67) 
W & S Africa 83 1301 56 
(44, 69) 




Table 1.1B: Mortality rates (1989-1992) for women for ischaemic heart disease 
by country of birth and sex for ages 45-74 years (unpublished analysis Wild S 
and Bhopal R) 




India 1020 1469 158 
(149,168) 
Pakistan 143 867 110 
(93,130) 
Bangladesh 26 509 94 
(62, 138) 
China 36 447 45 
(31,62) 
Caribbean 318 742 86 
(77,96) 
W & S Africa 20 757 67 
(41, 104) 
England and Wales 68810 739 99 
(98, 99) 
 
 *Directly standardised to the population structure of England and Wales in 10 year    
age bands. 
 **Standardised mortality rates, with the population as a whole as the standard (100).  
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Arguably, the most important message from Table 1.1 is that CHD is not simply an 
inevitable consequence of migration – witness the extremely low rates of CHD in the 
Chinese. 
 
Mortality data by ethnic group, as opposed to country of birth, are sparse, but early 
findings from the longitudinal survey are confirmatory in demonstrating that CHD is 
the dominant, and probably comparatively common, cause of death in South Asians.  




Incidence data of high quality are not available, but some work on hospital morbidity 
in ‘Asians’ in Leicester15 supports the mortality data.  Information on prevalence of 
cardiovascular diseases from many local studies10, and most recently the Health 
Survey for England ’99, confirm that CHD (angina and heart attack) and stroke are 
very common - and the prevalence is higher than, or on a par with, that in the 
reference white or general populations.  Table 1.2 is an extract of data from the Health 
Survey for England ’9913, on IHD and stroke combined.  The point is to show the vast 
scale of the problem.  About one-fifth of South Asian men and about one tenth of 
women report these problems – and this, of course, excludes those who are dead.  
Table 1.3 shows the age standardised prevalence rate ratios, thus permitting more 
direct comparisons between groups.  While the picture is not as clear cut as for 
mortality data, as discussed elsewhere10, we see that on several measures the South 
Asian groups had more CHD than the general population, and nearly always more 
than the other ethnic groups, i.e., Chinese and African-Caribbean.  It is worth noting 
that on the objective indicator of major Q waves on ECG, Indian men had 
substantially lower comparative prevalence than Pakistani and Bangladeshi men.  This 
is important because the validity of self-reported data in multi-ethnic studies where 
languages and cultures differ is open to question. 
 
For women the data were much less clear.  Indian women reported both less angina 
and heart attack and had a lower comparative rate of Q waves on ECG.  Self-report 
data on Pakistani and Bangladeshi women were inconsistent, but Q waves on ECG  
  6 
 
Table 1.2: Prevalence of IHD (heart attack or angina) or stroke by ethnic group 
(not age adjusted). Extracted from the Health Survey for England 199913. 
 
 I P B C BC G 
Men -16 and over 8.2 
 
4.8 5.1 2.9 4.8 8.5 
Men - 55 and over 29.2 
 
21.3 17.8 9.7 12.4 21.9 
Women -16 and over 2.3 
 
2.6 1.9 0.6 2.8 6.2 
Women - 55 and over 10.1 
 
16.8 6.3 2.5 8.9 15.5 
 
Table 1.3: Directly standardised prevalence rate ratios for cardiovascular 
diseases (general population = 100) Extracted from the Health Survey for 
England 199913. 
 
 I P B C BC 
Men 
 
     
Angina – self reported 











Heart attack - self reported 











ECG - major Q waves 86 147 178 60 68 
Women 
 
     
Angina - self reported 











Heart attack - self reported 











ECG - major Q waves 84 92 20 65 66 
 
I (Indian), P (Pakistani), B (Bangladeshi), C (Chinese), BC (Black Caribbean), G 
(General population), RQ (Rose angina questionnaire), MI (myocardial infarction) 
 
were comparatively less common, and in Bangladeshi women the ratio of 20% seems 
so low that it needs verification.  The Newcastle Heart Project12 only had 56 
Bangladeshi women but none had probable CHD on ECG criteria, and the proportion 
with possible CHD on ECG criteria was, at 13%, lower than Indians, Pakistanis and 
Europeans. 
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As ethnic monitoring is not mandatory within primary care, there are currently little 
routine data available. However, data are available from the National Morbidity 
Statistics from General Practice study done in 199116.  Essentially 60 practices in 
England and Wales provided data for one year, on face-to-face contact with 502,493 
patients.  2% of these patients were from ethnic minority groups compared to 6% in 
the 1991 census.  Gill et al reported a re-analysis of the data11.  This new analysis 
included consultations with a nurse (although the study did not record nurse 
consultations if a doctor was also consulted during the same visit).  The standard 
population for calculating the standardised patient consulting ratios (SPCR) was the 
entire study population including those for whom there was no ethnicity code (17% of 
patients).  Interpretation of the data requires caution as the sample was not 
representative, and the number of people was small. 
 
In Indians, circulatory diseases were not one of the dominant presenting problems but 
the standardised ratio was comparatively high for endocrine disorders (ration 176 in 
men, 139 in women) and circulatory conditions (ratio in men 135 and in women 117). 
For Pakistanis the standardised ratio for the circulatory system was comparatively low 
(ratio 99 for men, 80 for women).  There was a substantially raised standardised ratio 
for endocrine disorders.  For Bangladeshis there was a high standardised ratio for 
endocrine diseases; and a huge difference in men (standardised ratio 144) and women 
(ratio 66) for circulatory disorders.  The overall message from the morbidity data is of 
a substantial burden of disease, but with less excess in comparison to the population 
as a whole, than shown in mortality data10, 11.  These findings also point to major 
differences between subgroups of the South Asian population and to differences 
between men and women.  The low rates of CHD mortality in Bangladeshi women are 
echoed in the primary care morbidity data and in the prevalence of Q waves on ECG. 
 
Hypotheses relating to ethnic variations and the excess in South Asians 
 
 
The question of why South Asian populations are more susceptible to CHD will be 
explored from numerous perspectives. In general terms the explanations are: 
1. The high and excess mortality rates are statistical artefact.  This is unlikely to 
be more than a partial explanation although it merits more attention than it has 
received. 
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2. South Asians are more susceptible for genetic reasons. 
3. South Asians are more susceptible for non-genetic reasons, e.g., from metabolic 
adaptation in early life, then dysadaptation in later, middle age. 
4. The prevalence of classical causal factors is comparatively high in South 
Asians.  This holds for insulin resistance and diabetes (all South Asian groups), 
smoking in Bangladeshi men, and lack of physical activity (all South Asian groups).  
It does not hold for smoking (in most South Asian groups), blood pressure and 
cholesterol. 
5. The prevalence of risk factors other than classical ones is high, e.g., Lp(a), 
homocysteine, infection, poverty, stress, etc. 
6. There is a potent interaction of known causal factors specific to South Asian 
groups. 
7. South Asians are less likely to die of other important causes, e.g., cancer, so a 
high rate of CHD is the consequence (the competing causes hypothesis).  If the 
suggestion of a higher mortality without corresponding excesses in morbidity is 
corroborated, then this concept and difference in case fatality will need deeper study. 
 
Many specific explanatory hypotheses have been generated but have not been studied 
with prospective research designs, in the required range of ethnic groups, in 
population settings and with sample sizes with sufficient power.  Work thus far has 
generated numerous ideas including the effects of stress and racism, the use of ghee 
and other cooking oils, sub-clinical hypothyroidism, central obesity, insulin 
resistance, a thrifty genotype, a thrifty phenotype, low vitamin C, high homocysteine, 
endothelial dysfunction, differences in microalbuminuria, a greater burden of 
infection, high levels of Lp(a) and other specific lipid abnormalities.  The possibility 
of varying susceptibility has been raised but a formal hypothesis has not been 
systematically studied.  Rapid change in some risk factors may per se confer a risk 
beyond that predicted by a single measure e.g. Punjabis in Southall had a mean serum 
cholesterol of 6.5 mmol/l compared with 4.9 mmol/l for their siblings in Punjab, 
India17.  By inference, this reflects a rise after migration.  Box 1.2 summarises many 
of the hypotheses discussed above. 
 Box 1.2: Some hypotheses to explain ethnic variations in cardiovascular disease  
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 Hypothesis  Status 
 Variation in case fatality  Not studied but unlikely to be the full 
explanation. 
 Variation in prevalence of 
established classical risk factors 
 Rejected, mainly from cross-sectional data, 
with limited prospective studies.  Needs 
fresh evaluation. 
 High prevalence of diabetes  Accepted as partial explanation. 
 Insulin resistance  Under rigorous test, with evidence of some 
limited explanatory value independent of 
diabetes 
 Hyperhomocysteinaemia  Supportive evidence from cross-sectional 
data 
 Psychosocial factors increasing stress  Not tested formally.  Evidence of potential 
relevance from cross-sectional studies. 
 Socio-economic factors  Limited test in cross-sectional studies, but 
generally accepted not to fully explain 
ethnic group differences. 
 Racism  Not tested in the UK 
 Lp(a) excess  Under test in cross-sectional research 
 Chronic inflammation  Not tested, with limited data at cross-
sectional level 
 Adaptation–dysadaptation hypothesis  Some evidence from India 
 Genetic factors, and gene-
environment  interactions 
 Not tested in a systematic way. 
 Access and quality of health care.    Not tested in a systematic way. 
 Varying effects of risk factors  Suggested but never tested in a formal way 
 
One interesting explanation that has engaged attention is that South Asians have more 
insulin resistance, that is, they require larger amounts of the hormone insulin to 
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maintain a normal blood sugar.  This may be the result of different metabolism 
resulting from either genetic factors or environmental factors, or both.  The fact that 
South Asians have more of their body fat on the trunk, rather than limbs, and such fat 
has different metabolic characteristics is possibly important here.  These ideas are 
being explored intensively. 
 
Another explanation which seems important is that adverse circumstances in the 
womb and early life increase the risk of a number of health problems, including CHD.  
The explanation offered is that metabolism is programmed in early life.  If later there 
is a mismatch between the metabolism a person is programmed for and the lifestyle 
adopted, disease occurs.  If the critical factor was a change in life circumstances, from 
that of the relatively poor, to that of the relatively wealthy, this explanation might 
apply to migrant groups who make that transition. 
 
An overview of risk factors – the basis for prevention and control of CHD 
 
While CHD mortality risk, to a large extent, is shared across South Asian subgroups, 
most risk factors vary enormously.  Some data extracted from the HSE ’99 is given in 
Table 1.4 (A for men B for women) and the text below also relates to the data in Gill 
et al’s health needs assessment 11.  Other papers in this monograph will deal with 
several of these risk factors in detail. 
 
Indians are extremely heterogeneous, so findings are likely to differ in different 
places, and communities.  In particular, religion has an important effect.  For example, 
smoking is much less common in Sikhs than Hindus.  The reverse applies to drinking 
alcohol.  Indians have substantial needs in relation to smoking, alcohol and lack of 
physical activity.  In women the cultural taboo against smoking is holding, for the 
present, but it is likely to relax in time with a consequent rise in the consumption of 
tobacco. 
 
Table 1.4A: Pattern of key cardiovascular risk factors – prevalence (%) means 
and age standardised ratios in men. Extracted from the Health Survey for 
England ’9913. 
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 I P B C BC G 
 
 % Current smoker 23 26 44 17 35 27 
 - Ratio 78 90 157 62 126 100 
 No physical activity (30 mins) in 
past 4 weeks 
30 32 49 31 24 23 
 - Ratio of number of days 82 67 52 65 109 100 
 Mean systolic blood pressure  134 130 127 131 136 137 
 -Ratio of mean systolic pressure 100 98 94 97 100 100 
 Obesity (BMI > 30kg/m2) 12 13 5 6 18 19 
 - Ratio 66 74 32 38 102 100 
 LDL cholesterol (mean mmol/l) 3.5 3.2 3.3 3.4 3.30 3.5 
 - Ratio 100 91 94 95 98 100 
 HDL cholesterol (mmol/l) 1.3 1.1 1.1 1.3 1.5 1.3 
 - Ratio 99 87 83 101 114 100 
 
 
  Table 1.4B: Pattern of key cardiovascular risk factors – prevalence (%) means 




I P B C BC G 
 
 % Current smokers 6 5 1 9 25 27 
 - Ratio 19 14 7 31 85 100 
 No physical activity (30 mins) in 













 - Ratio of number of days 71 62 37 72 105 100 
 Mean systolic blood pressure 126 123 120 125 129 133 
 - Ratio 99 102 97 98 101 100 
 Obesity (BMI > 30kg/m2) 102 161 63 20 160 100 
 LDL cholesterol (mean mmol/l) 3.1 3.0 - 2.9 3.1 3.5 
 - Ratio 99 89 - 94 95 100 
 HDL Cholesterol 1.4 1.4 1.3 1.6 1.6 1.6 
 - Ratio 92 88 88 99 103 100 
 
 
  I (Indian), P (Pakistani), B (Bangladeshi), C (Chinese), BC (Black Carribean), G 
(General population) 
 
Vigorous action to control dyslipidaemia is warranted.  Indians are relatively short 
and obesity (particularly central) is common.  Indians born in the UK are growing 
taller than their parents.  Blood pressures vary in different Indian communities, with 
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the best judgement being that levels are similar to the white population, i.e. 
hypertension is a common disorder.  Diabetes and the associated syndrome of insulin 
resistance are exceptionally common in men and women. 
 
Pakistanis are mainly Muslims, whose religion impacts in ways important to health.  
Although heterogeneity between Pakistani communities should not be overlooked, 
this is less so than in Indians.  As with Indians there are substantial needs in relation 
to smoking (men) and in promotion of physical activity.  Few people drink alcohol, 
though the taboo against it may lead to underreporting.  Those Pakistanis who do 
drink may have special difficulties due to social problems arising from admitting to an 
alcohol problem.  
 
The comments above on lipids and physical measures of health including obesity in 
Indians, apply with even greater force in Pakistanis whose rates of heart disease and 
diabetes are slightly higher than in Indians.  The reduction of cardiovascular and 
diabetes risk factors is the prime health need in Pakistani adults. 
 
Of the South Asian populations in the UK the Bangladeshis are the most 
homogeneous, having in common a single major religion, Islam, and origins from a 
small country, Bangladesh, and within that many Bangladeshis come from Sylhet.   
Smoking prevalence in Bangladeshi men is exceptionally high, making this the 
priority public health issue.  Although the prevalence of smoking is relatively low in 
Bangladeshi women tobacco chewing (with betel nut or paan) is a common practice, 
and much more so than in Indian or Pakistani women.  The points made on alcohol 
use in Pakistanis apply to Bangladeshis too.  The exceptionally low rates of physical 
activity (a major issue) need to be interpreted in the knowledge that most men are in 
manual occupations.  Lipid patterns in Bangladeshis are problematic with the 
apparently low total cholesterol being a result of very low HDL cholesterol.  This 
together with high triglycerides signifies a need for dietary advice and change. 
 
Bangladeshis are very short, a reflection of poor nutrition in childhood.  In 
comparison with other ethnic groups, Bangladeshis have less obesity and a lower 
mean blood pressure.  This should not lead to complacency for their risk of 
developing cardiovascular disease and diabetes is the highest of all the ethnic groups 
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considered here, at least in men.  It may be that cardiovascular risk is triggered at a 
lower threshold than in other ethnic groups.   
 
Conclusions and recommendations 
 
CHD is higher in South Asian groups than in the population as a whole, with 
increasing evidence that men in the poorest groups, of Pakistani and Bangladeshi 
origin, have the highest rates.  The causes of the excess are incompletely understood.  
Recent work indicates that socio-economic factors are important.  The role of the 
classic risk factors (high blood pressure, lipids, smoking) is vital.  Central obesity and 
insulin resistance are two other factors of especial note. 
 
The scale of the challenge, summarised in box 1.3, is too great for solitary and 
fragmented effort.  The control of the CHD epidemic in South Asians requires a co-
ordinated, vigorous response based on established principles and available evidence 
on effectiveness, and standards of care specified in guidelines such as the National 
Service Framework on CHD 18.  Practitioners must not await specific evidence from 
trials on South Asian populations (these are rare) or be deflected by scientific 
controversy.  We should: 
 
1. Adopt broadly based strategies that focus on the established risk factors, take 
account of language and cultural needs, consider the issue of relative poverty 
(especially in Bangladeshis) and appreciate the heterogeneity of South Asians. 
2. Ensure that each of the known risk factors are vigorously tackled, including 
smoking cessation which has been relatively neglected.  Smoking cessation services 
need to be targeted at Bangladeshi and Pakistani men, and at all South Asian 
teenagers.   The other key risk factors requiring vigorous control include diabetes, 
hypertension, obesity, high fat diet, raised LDL cholesterol and lack of physical 
exercise.  Disease registers and practice lists may need a valid ethnic code so services 
can be targeted. 
3. Use specific research in South Asians to help refine the above strategies.  The 
main lesson to date is that practitioners should be particularly vigilant in controlling 
risk factors, for thresholds for intervention may be lower than in European origin 
populations (a topic for new research). 
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4. Ensure that South Asian patients are well informed about CHD (there is 
evidence that their knowledge is low 19).  Community involvement will be needed to 
devise effective actions. 
5. Apply and audit agreed standards of care to achieve equity between ethnic 
groups in the quantity and quality of care. 
 
Box 1.3: Challenges of ethnic variations in CHD  
 
1. Inclusion of the ethnic dimension without dividing society or creating racial 
disharmony. 
2. Creation of reliable information systems that provide information by ethnic, 
religious and language group. 
3. New and more stringent targets for disease control based on ethnic groups 
with the lowest rates of CHD. 
4. Value, learn from and utilise the heterogeneity of ethnic minority 
populations in both research and prevention. 
5. Seek understanding of differences in CHD frequency, i.e. hypothesis 
testing. 
6. Validate measurement methods for mortality, morbidity and risk factor data.
7. Reduce disease (and risk factor prevalence), particularly in ethnic minority 
groups with high rates. 
8. In relation to preventive and therapeutic services avoid veering away from 
established paths, based on controlling the major classical risk factor, too 
readily. 
9. Achieve equity in service delivery, quality and outcome. 
 
The South Asian community must be alerted to the epidemic and know the symptoms 
and signs of CHD so that early medical advice is sought.  For South Asians, CHD will 
be a key health problem for many decades. 
From the perspective of national and local government and the National Health 
Service lost time needs to be made up.  It seems incredible, looking back, that while 
attention focused on the "specific problems" of ethnic minority groups (e.g. birth 
control, weaning, rickets, surma, traditional medicines and macrocytic anaemia) an 
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epidemic of cardiovascular disease was sweeping through the South Asian 
community, being the underlying cause of up to 50% of deaths.  Why was this 
unnoticed?  Why were there virtually no educational materials adapted or developed 
for ethnic minority groups until the last few years?  These key questions reach to the 
core of the decision making process in research and health policy. 
 
We need policies which offer equity in opportunity for escaping social and economic 
deprivation, and which give incentive to the NHS to meet both the mainstream and 
additional needs of ethnic minorities.  The NHS needs to achieve the same levels of 
communication with, and quality of care for, South Asians as it does for the general 
population.  The achievement of such equity will require targeting of resources. 
 
South Asians comprise one-quarter of the world's population.  Globally, the epidemic 
in these populations threatens the international effort to bring the CHD epidemic to 
heel.  South Asians comprise a substantial proportion of the population in most 
modern economies, particularly Britain.  In Britain, South Asians are scattered 
throughout the country, so it is important that groups outside the London and 
Midlands areas are not overlooked. 
 
Understanding cardiovascular diseases better will be of benefit nationally, not just to 
South Asians.  Improving services to South Asians will, inevitably, raise standards for 
the whole population, and particularly other groups that are suffering from low quality 
or inequitable service.  The work on CHD done in the U.K. will have global interest 
and value for CHD is poised to be the predominant killer in developing and 
industrialised countries alike. 
 
The South Asian Health Foundation (SAHF), a new charity, has chosen a worthy 
challenge. SAHF has the potential to catalyse research in ethnic minorities and to 
foster high quality facilitation at educational events.  SAHF's future symposia intend 
to involve a wider audience and reach out to all health care and allied professionals so 
that we can apply research from the cell to bedside to population. 
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2 
 
Conceptualising the causes of coronary 
heart disease in South Asians  
 




As discussed by Bhopal in the previous chapter, the burden of cardiovascular disease 
is greatest amongst South Asians living in urban areas1 and overseas compared to 
appropriate comparison populations2-9. South Asians represent the largest ethnic 
minority group in the UK. Amongst UK South Asians, mortality from coronary heart 
disease (CHD) is approximately 40% higher2,3,  and admission rates with myocardial 
infarction in one study were 2-fold higher10 when compared with white Europeans. 
The increase in CHD risk is evident in each of the major South Asian subgroups11,12 
and is most striking in young males, amongst whom CHD mortality is at least 2-fold 
higher than in their white European counterparts2.  
 
Risk factors underlying CHD in South Asians 
 
Diabetes and insulin resistance 
Population studies have consistently identified a high prevalence of non-insulin 
dependent diabetes amongst urban and overseas South Asians. The prevalence of 
diabetes is reported as 2-5% in rural Indians, 5-10% in urban Indians, and almost 20% in 
UK South Asians, compared to 4% of white European males13-21.  In the UK, South 
Asians develop diabetes on average 10 years earlier than their white European 
counterparts22, and South Asians with diabetes show a markedly increased predisposition 
to cardiovascular disease. In a large prospective study, cardiovascular and CHD 
mortality were higher amongst South Asians with diabetes, compared with white 
Europeans23. Furthermore, circulatory disease accounted for 77% of deaths amongst 
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South Asians, compared with 46% amongst white Europeans23. In addition to the high 
prevalence of diabetes, insulin resistance and its related metabolic abnormalities (central 
obesity, glucose intolerance, elevated plasma insulin, increased triglycerides, raised PAI-
1 (plasminogen activator inhibitor), and reduced HDL (high-density lipoprotein 
cholesterol)) are more common amongst South Asians than white European populations 
(Table 2.1)18,20,21,24.  It is estimated that diabetes and insulin resistance may account for 
up to 70% of major Q wave ECG abnormalities in UK South Asians25.  
 
Table 2.1. Coronary risk factors amongst UK South Asian and white European 
males in West London (adapted from ref. 18).  
 
 









Cigarette smoking (%) 30 4 21 33 30 
Systolic BP (mmHg) 121 128 126 122 120 
Total cholesterol 
(mmol/L) 6.1 6.1 5.9 5.5 6.0 
Diabetes (%) 5 20 19 22 19 
Waist-hip ratio 0.93 0.98 0.98 0.98 0.97 
2hr insulin (mU/L) 19 39 42 49 43 
 Fasting triglycerides 
(mmol/L) 1.48 1.73 1.74 1.49 1.85 
 HDL cholesterol 
(mmol/L) 1.24 1.22 1.17 1.14 1.04 
 
 
The mechanisms underlying the relationship between insulin resistance and CHD remain 
to be determined. Hyperglycaemia, hyperinsulinaemia, dyslipidaemia, a prothrombotic 
state, and hypertension may each have a separate contribution26-28.  Elevated fasting and 
post-glucose load glucose concentrations are associated with increased risk of CHD, 
even in subjects without diabetes29-31.  Hyperglycaemia may contribute to accelerated 
atherosclerosis through glycation of collagen and lipoproteins, generation of reactive 
oxygen species, and impaired vascular endothelial function, as discussed by Shah and 
Kearney in chapter 432-34.  Hyperinsulinaemia may promote atherosclerosis through 
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increasing blood pressure, smooth muscle cell proliferation, release of PAI-1, and 
inhibition of fibrinolysis27,35,36.  However, the beneficial effects of insulin therapy on risk 
of CHD events in patients with type 2 diabetes argue against hyperinsulinaemia as the 
primary atherogenic defect in insulin resistant states. A reduction in insulin mediated 
adipocyte lipogenesis secondary to insulin resistance may be of more importance28,.37.  
Insulin resistance is associated with increased levels of free fatty acids, which leads to an 
increase in hepatic VLDL synthesis, hypertriglyceridaemia, a reduction in HDL 
cholesterol and an increase in atherogenic small dense LDL28,38.  This pattern of 
dyslipidaemia is associated with increased entry of cholesterol into, and reduced 
clearance of cholesterol from, the arterial wall. Observations that CHD mortality is low 
in Afro-caribbeans3,39 who have a high prevalence of insulin resistance and hypertension, 
but a favourable lipoprotein profile40,41,  suggest that the dyslipidaemia associated with 
insulin resistance may underlie CHD. However, the validity of this view is open to 
debate and discussed in later chapters. 
 
Conventional CHD risk factors 
High CHD mortality is shared by Hindu, Sikh and Muslim Asians11,12. In contrast, 
population studies have shown that levels of cigarette smoking, blood pressure and 
cholesterol, are not consistently raised in all South Asian groups (Table 2.1). These 
findings have led to the belief that conventional risk factors alone do not contribute to 
high CHD mortality rates in Asians despite making an important contribution18.  
 
The importance of conventional risk factors underlying increased CHD risk in urban, 
and overseas South Asians is further illustrated by comparisons of risk factors between 
migrant, and non-migrant Asians. Serum cholesterol, blood pressure, smoking rates, and 
BMI are all substantially higher in urban compared to rural Indians42-46.  Similar 
differences exist amongst overseas South Asians compared to their non-migrant 
siblings47 (Table 2.2). These observations support the view that classic risk factors 
impact on the high CHD rates in urban, and overseas South Asians, although the precise 
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Other risk factors for CHD  
A key question is whether diabetes, insulin resistance and the established CHD risk 
factors account for the increased risk of CHD amongst South Asians, compared to 
other populations. To date, no large scale prospective study has examined CHD 
mortality in South Asians, or its relationship to CHD risk factors. Much of the 
evidence is based upon the results of cross-sectional studies, which have compared 
risk factors between South Asians and other population groups. In West London, there 
was a 1.4-fold excess of pathological Q waves, a surrogate marker of CHD, amongst 
South Asians compared to Europeans25. After adjustment for age, smoking, 
cholesterol, fasting and 2 hour insulin, waist-hip ratio and glucose intolerance, there 
remained a 1.5-fold excess of pathological Q waves amongst South Asians. Similarly 
in Canada, South Asian ethnicity is associated with an excess of prevalent CHD, that 
is not accounted for by conventional risk factors, diabetes, HDL cholesterol, PAI-1 or 
fibrinogen24. The results of these studies suggest that other risk factors contribute to 
the observed excess CHD mortality amongst South Asians. 
 
a) Inflammation and CHD in South Asians 
Inflammation, as discussed later by Gupta in chapter 7, is now widely recognized as a 
central feature of atherogenesis, and in particular seems to play a critical role in 
destabilization of the fibrous cap tissue, predisposing to plaque rupture48. C-reactive 
protein (CRP), the classical acute phase reactant, is an extremely sensitive systemic 
marker of inflammation.  
 
Recent studies indicate that CRP concentrations are higher in healthy asymptomatic 
South Asians, than in white Europeans49. In both populations CRP concentrations are 
closely associated with central obesity, and markers of insulin resistance (Figure 2.1). 
This is consistent with experimental studies which suggest that abdominal adipose 
tissue is a major source of cytokines, including IL-6, an important determinant of 
hepatic CRP synthesis50,51.  The difference in CRP concentrations between South 
Asians and Europeans may be accounted for by the higher level of central obesity and 
insulin resistance in Asians49. These observations suggest that inflammatory activity is 
increased amongst South Asian, and white European subjects with the insulin 
resistance syndrome, and raise the possibility that inflammatory mechanisms underlie 
part of the increased risk of CHD, amongst insulin resistant South Asians. 
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Table 2.2. Coronary risk factors amongst UK South Asian men in West London, 
and their non-migrant male siblings in India (adapted from ref. 47). (NS=non 
significant) 
 
 West London Punjab P= 
Age (years) 46.0 ± 10.6 44.4 ± 9.4 NS 
Body mass index (kg/m2) 26.8 ± 5.2 22.9 ± 4.7 <0.001 
Systolic BP (mmHg) 146 ± 23 132 ± 22 <0.001 
Diastolic BP (mmHg) 93 ± 14 87 ± 12 <0.001 
Total cholesterol (mmol/L) 6.5 ± 1.4 4.9 ± 1.1 <0.001 
HDL cholesterol (mmol/L) 1.12 ± 0.45 1.21 ± 0.43 NS 
Triglycerides (mmol/L) 2.10  (1.88-2.35) 2.06 (1.78-2.38) NS 
Fasting glucose (mmol/L) 5.7 ± 1.4 4.5 ± 1.0 <0.001 
Fasting insulin (mU/L) 8.4 (7.2-9.8) 6.7 (5.4-8.4) NS 
 
 
Figure 2.1: Comparison of CRP concentrations between healthy asymptomatic 
South Asians and white Europeans 
 
3
UK South Asians 
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b) Endothelial dysfunction and CHD in South Asians 
Endothelium dependent dilatation is impaired in healthy UK South Asians compared 
to white Europeans and is discussed further by Shah and Kearney in chapter 4.  
 
c) Homocysteine and risk of CHD in South Asians 
Recent studies show that concentrations of plasma homocysteine, an emerging risk 
factor for CHD, are higher in South Asians than white Europeans20,24,52, suggesting that 
elevated homocysteine may contribute to increased CHD mortality in South Asians. 
Amongst South Asians, elevated homocysteine is accounted for by reduced 
concentrations of vitamins B12 and folate, compared to white Europeans20. In contrast, 
the MTHFR C677T mutation, identified as a major determinant of homocysteine 
concentrations in Europeans, is less prevalent and does not influence homocysteine 
concentrations in South Asians53. Whether the increased CHD risk in this group can be 
reduced by dietary supplementation with homocysteine-lowering B vitamins54, remains 
to be determined.  
 
d) Lipoprotein (a) 
Lipoprotein (a), formed from the assembly of the protein apolipoprotein (a), has been 
identified as an independent risk factor for vascular disease, including CHD55-57.  The 
mechanisms underlying this relationship is uncertain, but in vitro studies suggest that 
lipoprotein (a) may influence cholesterol uptake, and inhibit fibrinolysis55. Serum 
lipoprotein (a) concentrations are influenced primarily by genetic factors58, with over 
30 apolipoprotein (a) alleles identified to date59. Lipoprotein (a) concentrations are 
reported to be higher in South Asians compared to white Europeans, and Chinese, and 
may influence CHD risk in this group24,47,60.   
 
e) Low birth weight 
South Asian babies are small compared to other populations. The average weight of a 
newborn native Indian is 2.7kg, compared with 3.1kg in UK South Asians, 3.2kg in 
Chinese and Afro-Caribbean’s, 3.4kg in Caucasians, and 3.7kg in North American 
Indians (Table 2.3)61-66.  The possibility that low-birth weight may contribute to 
increased risk of CHD amongst South Asians is supported by observations that the 
prevalence of CHD is significantly higher amongst Indians with birthweight <2.5kg, 
compared a birth-weight >3.2kg. This is discussed further by Fall in chapter 5. 
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f) Socio-economic factors  
South Asians are more likely to live in areas with increased social and economic 
deprivation67. In addition, the results of several studies provide evidence that UK 
South Asians have different access to health care. Although South Asians are more 
likely than Europeans to seek medical advice for symptoms suggestive of angina68, 
regional studies suggest that South Asians may be less likely to be referred for 
exercise testing, wait longer to be seen by a cardiologist, wait longer for angiography, 
and be less likely to receive thrombolysis for acute myocardial infarction69-72.  The 
contribution of socio-economic deprivation, and reduced provision of healthcare 
services, to increased CHD mortality needs wider investigation and is discussed 
further in chapter 12 by Williams and Harding. 
 
Table 2.3. Mean birth weight, and incidence of low birth weight (<2500g), 





Incidence of  
low birth weight (%) 
South Asian 3082 ± 527 10.1 
Afro-Caribbean 3156 ± 604 9.4 
African 3214 ± 617 9.2 
Oriental 3231 ± 532 6.6 
White European 3377 ± 548 5.0 
 
 
Mechanisms underlying diabetes and insulin resistance in South Asians 
 
Many accept the notion that diabetes and insulin resistance are major determinants of 
the increased CHD mortality amongst UK South Asians. Reasons underlying the 
higher prevalence of insulin resistance in UK South Asians are not known. Studies in 
white Europeans indicate that diabetes and insulin resistance may be influenced by 
genetic and environmental factors, the latter include reduced physical activity, 
increased weight, and dietary intake. 
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Environmental factors 
UK South Asians have higher glucose and insulin concentrations, an increased 
prevalence of diabetes, and lower HDL cholesterol, compared to non-migrant Asians 
(Table 2.2)47. These observations demonstrate that environmental factors may 
contribute to insulin resistance in UK South Asians. 
 
1. Obesity 
Amongst Europeans, obesity, and in particular visceral adiposity, is associated with 
reduced insulin sensitivity, and an increased risk of diabetes and CHD73. Population 
studies have shown that UK South Asians (except Bangladeshis) have similar BMIs, 
to white Europeans18,20,24,74,75.  Although this might suggest that adiposity does not 
account for insulin resistance amongst South Asians, this comparison may be 
misleading, since South Asians have greater visceral adiposity than white Europeans, 
for the same level of BMI18,74,75.  Previous studies show that visceral adiposity is 
closely associated with insulin resistance and its related metabolic disturbances, 
diabetes, inflammation, and CHD, amongst South Asians18,25,49,74-76.  The reasons 
underlying the disproportionate increase in visceral adiposity amongst UK South 
Asians are not known.  
 
2. Dietary factors 
Diet plays an important role in the development of insulin resistance. In North 
American and white European populations, a diet high in saturated fatty acids is 
associated with obesity, hyperglycaemia and hyperinsulinaemia77-79  and an increased 
risk of diabetes and CHD79-85.  In addition, trans fatty acids (TFA), primarily derived 
from commercial hydrogenation of polyunsaturated oils86 have been associated with 
raised triglycerides, and raised total to HDL cholesterol ratio, and an increase in post-
prandial hyperinsulinaemia, suggesting an effect of TFA on insulin sensitivity87,88.  
Diet may also have protective factors. Starchy foods producing relatively flat 
glycaemic responses, are associated with weight loss, reduced blood pressure, and 
lower glucose, insulin, and lipid levels89,90.  Phytoestrogens such as genestein and 
daidzen, may also confer protection from atherosclerosis, through an action on the 
oestrogen receptor. Phytoestrogens raise HDL cholesterol, and lower total cholesterol 
and total / HDL cholesterol ratio, and may improve insulin sensitivity91,92.   
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The dietary mechanisms underlying the increased prevalence of insulin resistance, and 
related metabolic disturbances, amongst UK South Asians are not known. Studies 
based upon weighed 7-day food diaries, have reported that UK South Asians have 
higher intakes of polyunsaturated fat, and carbohydrate, and lower total and saturated 
fat intakes, compared to White Europeans (Table 2.4)93. In this study, insulin levels 
were closely correlated with total and saturated fat intake in Europeans only, 
suggesting that dietary fat may contribute to reduced insulin sensitivity in Europeans, 
but not Asians. These observations have lead some to describe the diet of UK South 
Asians as favourable and to propose that increased insulin resistance in South Asians 
is largely determined by genetic factors. 
 
Table 2.4. Dietary intake amongst rural South Asians, UK South Asians, and 
white Europeans (adapted from refs. 93 and 94).  
 
 South Asians 
 Rural S Asia Urban UK UK 
European 
whites 
Energy (MJ/day) 9.2 8.9 9.5 10.8 
Fat (% of energy intake) 15 25 37 39 
Polyunsaturate / saturate ratio 0.66 0.62 0.50 0.40 
Carbohydrates (% of energy intake) 73 62 46 41 
Protein (% energy) 12 13 14 15 
Fibre (g/day) 24 25 29 18 
 
 
However, there are important limitations in our understanding of the relationship 
between environmental factors and insulin resistance in UK South Asians. The 
relationship of dietary intake with concentrations of HDL cholesterol, triglycerides, 
and glucose (key components of the metabolic syndrome), or with other conventional 
CHD risk factors, has not been investigated. Similarly, there is a paucity of data on 
the intake of TFAs, high-glycaemic foods, and of phyto-oestrogens in South Asians 
(as reviewed by Sanders in chapter 9). Furthermore, studies based on 7-day food 
diaries have important limitations. Food diaries rely upon accurate knowledge of the 
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nutritional content of individual foodstuffs. Whilst some of this information is 
available from sources such as the UK Food Tables, nutrient content is not available 
for many European dishes, and is limited for many South Asian foods.  
 
Comparisons between Europeans and South Asians, also do not address the changes 
in insulin sensitivity that have occurred with migration from India. Indeed, no study 
has examined the dietary changes that have occurred with migration, and their 
possible contribution to insulin sensitivity amongst UK South Asians. Observations 
that total fat constitutes less than 15% of energy in rural India, compared with over 
30% in the UK (Table 4.4)94, suggest that increased total or saturated fat intake may 
contribute to reduced insulin sensitivity in UK South Asians. Careful studies of the 
differences in dietary habit between UK and non-migrant South Asians, are needed to 
define the role of diet in determining CHD amongst UK South Asians. 
 
3. Physical activity 
Physical inactivity is recognised as a risk factor for diabetes, obesity, CHD, and 
cardiovascular mortality in North American and white European populations95-98.  In 
prospective studies, physical inactivity increases risk of CHD by up to two-fold, 
comparable to the risk associated with conventional CHD risk factors such as 
cigarette smoking and hypertension. Increasing evidence suggests that the adverse 
effects of physical inactivity on CHD risk. may be mediated by insulin resistance. An 
increase in physical activity is associated with a reduction in weight, serum insulin, 
hyperuricaemia, diastolic blood pressure, and increased HDL cholesterol99. Increased 
physical activity may also prevent the onset of diabetes100. White, in chapter 12, 
discusses further physical inactivity in South Asians as a risk factor for CHD. 
 
4. Genetic factors 
Family studies, in other populations, have shown that a component of insulin 
resistance is inherited101. In Mexican Americans, insulin resistance segregates as a 
familial trait and evidence for linkage has been found between chromosome 6q and 
insulin action102. This chromosomal region contains the gene for a protein which may 
be an inhibitor of insulin-receptor tyrosine kinase103,104.  In white type 2 diabetic 
pedigrees, segregation analysis suggests the presence of a major autosomal locus 
determining 33% of the variance in fasting insulin105. Support for the hypothesis that a 
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component of insulin resistance is inherited in South Asians, comes from observations 
of hyperinsulinaemia and impaired NEFA suppression, after an oral glucose load, in 
non-diabetic first degree relatives of UK South Asian survivors of premature MI 
(Figure 2.2)106. In recent studies, an increase in central and generalised adiposity, both 
closely associated with insulin sensitivity in cross-sectional studies, have been linked 
to the –55 C-T mutations of the mitochondrial uncoupling protein UCP3107. However, 
the mutation is associated with obesity in females only, and there is no increased 
prevalence of the mutation amongst South Asians compared to Europeans. The 
genetic factors underlying reduced insulin sensitivity and increased CHD amongst 
South Asians remain to be determined and is further discussed by Samani and Sharma 
in chapter 6.  
 
Figure 2.2: Observations of hyperinsulinaemia and impaired NEFA suppression, 
after an oral glucose load, in non-diabetic first degree relatives of UK South 














Management of CHD risk factors in UK South Asians 
 
CHD has a multifactorial aetiology, and coronary risk factors have a multiplicative 
effect. Effective prevention therefore requires identification and treatment of the total 
burden of risk, rather than single risk factors.  
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Diabetes and Insulin resistance 
Cardiovascular disease is the principal cause of death amongst patients with diabetes23. 
The prevalence of diabetes is four-fold higher in South Asians than Europeans18-20, and 
diabetes is present in over 50% of South Asian CHD patients20. Diabetes is therefore of 
particular importance in this ethnic group. The results of recent studies amongst white 
Europeans provide unequivocal evidence that in patients with diabetes, the incidence of 
myocardial infarction can be reduced by 21% through rigorous blood pressure control 
(target: <130/80 mmHg), and by 16% through tight control of blood glucose (target: 
fasting plasma glucose <6.0 mmol/L)108,109.  Achieving these targets should be a priority 
in the management, and prevention, of CHD in UK South Asians. 
 
A major limitation in the treatment of insulin resistance, is the lack of solid evidence that 
improved insulin sensitivity is associated with a reduction in CHD mortality. 
Nevertheless, weight reduction, and increased physical activity are accepted measures to 
improve insulin sensitivity110,111,  and may prevent the onset of diabetes100. In the future, 
novel insulin sensitising agents, such as the thiazolidinediones, may have important 
consequences in South Asians112,113. Weight loss can be achieved merely by reducing the 
fat content of the diet without the need to voluntarily restrict food intake114. In UK South 
Asians, energy intake from fat is twice that of non-migrants115,116.  The most important 
practical measure is reducing the quantity of fat/oil used in preparation of foods. Most 
South Asians live in extended family units, and food is generally prepared at home. 
Targeted education of the 'shopper and cook' can be highly effective, and thus have a 
significant impact on the diet of other high-risk members of the family. Physical activity 
levels in Asians are low. Moderate activity including walking, swimming, cycling will 
have energy expenditures of about 100 kcal/h, and should be undertaken daily. It is 
important to maintain increased physical activity, otherwise the effects on insulin 
resistance are short lived. 
 
Conventional risk factors 
As discussed by Bhopal in chapter 1, cigarette smoking rates are higher in Bangladeshi 
men, and similar in other muslim men, compared to white Europeans. Cigarette smoking 
is one of the most important predictors of MI in South Asians117. For individuals 
currently smoking 10 or more per day the odds ratio for CHD is raised substantially. 
Often, success on smoking cessation is greatest after the acute event. Smoking cessation 
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may reduce CHD by about 25% in South Asian men. South Asian women have very low 
smoking rates. Health promotion such as that discussed by Zaidi in chapter 10, aims to 
ensure that smoking rates should not rise in second generation UK South Asians. 
 
Primary and secondary prevention studies show that cholesterol lowering reduces 
CHD risk, even amongst subjects with average cholesterol levels118-120.  In this regard, 
'normal' cholesterol levels, often based on a range between 4.0-6.5 mmol/l, should be 
re-defined. Total cholesterol levels have risen by almost 2mmol/L with migration to 
the UK from India47 and undoubtedly have a major influence on the high CHD rates 
in UK South Asians. Drug therapy to lower cholesterol should be considered in all 
high-risk South Asians, irrespective of baseline cholesterol level118. Many South 
Asians have high triglycerides and low HDL cholesterol, and increased small dense 
LDL cholesterol18,20,24,25.  The data from clinical and metabolic studies linking mild to 
moderate hypertriglyceridaemia and low HDL cholesterol to CHD is compelling119-121  
and would favour treatment of this atherogenic phenotype. Ideally, in UK South 
Asians, the lipid profile should be similar to non-migrants; total cholesterol should not 
exceed 4.5 mmol/, LDL cholesterol 2.5 mmol/l, triglycerides 1.5 mmol/l, and HDL 
cholesterol should be higher than 1.0mmol/l. These values are acceptable because 
they are similar to rural populations at low risk of CHD47.  
 
Hypertension in South Asians is discussed by Agyemang and Bhopal in chapter 8. 
Undoubtedly, raised blood pressure is a strong predictor of CHD122, and randomised 
trials indicate that antihypertensive therapy is effective in reducing CHD and stroke 
rates123,124. Active attempts should be made to detect, and control hypertension in South 
Asian subjects. In middle aged UK South Asians, blood pressure levels should probably 
not exceed the non-migrant blood pressure of 132/87 mmHg in men and women47. 
 
Identification of South Asians at increased CHD risk 
 
Therapeutic intervention to reduce CHD events should be directed to patients with 
proven CHD; first degree relatives of patients with premature CHD; and to individuals 
who are asymptomatic, but at high risk of CHD. To identify these high-risk persons, the 
American College of Cardiology, the American Heart Association, and the European 
Society of Cardiology, have recommended adoption of the Framingham CHD risk 
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assessment equations125-128. The Framingham equations predict CHD risk accurately 
amongst predominantly white populations in North America, and Europe129-132.  
However, the validity of extrapolating risk functions to populations other than those 
from which they were derived, remains to be established133.  
 
In recent studies we have evaluated the validity of the Framingham functions amongst 
UK South Asians134. We found that CHD mortality rates were almost 2-fold higher 
amongst South Asian, than white European males. In contrast, the CHD mortality rate 
predicted by the Framingham functions amongst a representative sample of UK South 
Asians, is no different to the predicted rate in Europeans. The Framingham functions 
therefore underestimate the risk of CHD amongst South Asians by approximately 50% 
(Figure 2.3)134. This may reflect the failure of these functions to take account of 
insulin resistance and related disturbances. A logical solution to this problem might be 
to lower the threshold for treatment in UK South Asians, although the validity of this 
approach remains to be determined.  
 
Identification of South Asians at increased CHD risk therefore presents a major 
obstacle for the clinician. Most studies support the view that insulin resistance is the 
key disturbance underlying increased CHD risk in UK South Asians. However, the 
absence of a simple, reproducible marker of insulin resistance presents a further 
problem to the clinician. In practice, the combination of raised fasting triglycerides 
(>1.5 mmol/l), low HDL cholesterol (<1.0 mmol/l), raised fasting glucose 
(>6.0mmol/l), central obesity (waist-hip girth ratio >1.0 in men, and >0.85 in women), 
and hypertension, reliably identifies insulin resistant subjects, who are likely to 
benefit most from risk factor modification. 
 
Conclusions and future directions 
 
Future work is necessary to identify the precise environmental and genetic 
mechanisms underlying insulin resistance and increased CHD risk in UK South 
Asians. Identification of dietary factors, and nutrient-gene interactions, underlying 
insulin resistance, and increased risk of CHD, amongst South Asians will enable 
formulation of novel strategies for dietary intervention for CHD in Asians. 
Investigation of the heritability of metabolic disturbances within large, extended 
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South Asian families, may provide important insights into genetic factors determining 
CHD risk. Large-scale association studies and ultimately whole genome association 
studies to discover patterns of genetic variation leading to insulin resistance and 
atherosclerotic CVD in the South Asians should provide key insights into metabolic 
pathways involved and disease pathogenesis. 
 
Figure 2.3: CHD risk prediction and observed rates of CHD in UK South Asians 
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3 
 
Coronary heart disease in South Asians: 
the impact of diabetes mellitus 
 




The key question posed by the title of this chapter is: “How much of the excess 
coronary heart disease (CHD) in populations of South Asian origin is related or even 
‘due’ to glucose intolerance or overt type 2 diabetes, with all the heterogeneity of 
culture, current geography and different environments”? Unfortunately, adequate data 
are not yet available to answer the question even approximately, mainly because 
cohorts of adequate sample size are not yet available. However, the difficulty is also 
in part because the notion of what diabetes is as a diagnostic entity is beginning to 
change and also because of the slow realisation that its metabolic precursors develop 
early in life (see chapter 4).  Excess diabetes continues to be a public health issue 
across all South Asian sub-groups in Britain since it was first described in 1980 and in 
the several surveys since (1-8).  Looking at the British reports, a key point that recurs 
throughout the literature is that the excess of diabetes, and frequently its prodrome, 
glucose intolerance, is also accompanied by a variety of other risk factor differences 
compared with those individuals still apparently normoglycaemic, South Asian or not, 
who remain at risk of developing these conditions later. 
 
Another way of posing this chapter’s question more technically is to ask, what is the 
population attributable risk from the upward shift in the blood glucose distribution of 
South Asians for incident coronary heart disease?  The ideal would be to compare 
outcomes of South Asian people with and without diabetes with the experience of 
other populations. Again, unfortunately, such data are scarce in any population. The 
best dataset for such comparison remains the largest available, with outcomes now 20 
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years since the original classification of men from the MRFIT study9.   Where would 
results for “South Asians” lie on this plot? 
Figure 3.1 Age adjusted cardiovascular death rates by systolic blood pressure (or 
other risk factors)  for men with and without diabetes at initial screening for 
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The global nature of diabetes among South Asians 
 
Diabetes is a global problem among people of South Asian origin, as previously noted 
in the mid 20th Century in the Caribbean10, South Africa11, Fiji12, and more recently in 
Mauritius13. Data from the subcontinent itself has begun to show similar high rates of 
diabetes14. Worryingly, in our comparison of British migrants from specific villages 
in Gujarat and people still resident in the same semi-rural area of origin there, rates of 
glucose intolerance and known diabetes were as high in India as in the UK population 
samples at some 15%. However, unlike other key underlying CHD risk factors, 
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glucose intolerance was the only one not to be greatly increased in the migrants, in 
whom for example body mass indices were a mean of 5 kg/m2 greater (paper 
submitted). Possibly, lifestyle changes had already been in process for these 
‘villagers’ so that their body mass indices, despite apparently still being ‘low’ at 
means of 21.5 kg/m2, were higher than appropriate for their body build and current 
local setting, perhaps in part because physical activity undertaken was less than that 
experienced 10 years earlier. Life and facilities had certainly changed over the 
previous decade in the greatly expanded and now bustling, traffic-hindered township 
around which their villages were located.   These data suggest that most of the excess 
vascular risk conferred on Indian migrants compared with their contemporaries still in 
their Indian villages of origin is due to substantial increases in standard risk factors, 
that is adiposity, high blood pressure and dyslipidaemia.  
 
CHD in diabetes itself 
 
In people already diagnosed with diabetes, very few studies have been conducted 
specifically to examine excess CHD risk, if any, associated with ‘South Asian’ 
ethnicity. An early report from Leicester, UK did find that the relatively high and 
excess CHD rate in mainly Gujarati people there was associated with diabetes but was 
not accounted for entirely by such known diabetes15. However, as the data were 
collected after the CHD event, the role of prior glucose intolerance and unknown 
diabetes could not be estimated. The UK Prospective Diabetes Study found slightly 
but not significantly higher age standardized rates for fatal and non- fatal myocardial 
infarction amongst South Asians with type 2 diabetes of 15.4 (95%CI 10.6-21.4) per 
1000 person years (ppy) compared with 14.6 ppy (13.3-15.9) in whites and 4.3 ppy 
(2.5-7.0) in African-Caribbeans16, although this was attenuated after adjustment for 
conventional risk factors.  
 
Causes of the excess glucose intolerance 
 
The causes of the excess glucose intolerance remain unclear. Insulin insensitivity or 
resistance, a descriptive term which throws little or no light on the aetiology of the 
hyperglycaemia (see section below), is a widespread finding and, together with actual 
levels of blood glucose, predicts those more likely to develop later diabetes, in South 
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Asian and other populations. However, contrary to an initial hypothesis, insulin 
resistance does not predict later CHD consistently in any population, and most 
particularly not at all to date in the three disparate Indian origin populations studied, 2 
in London17 and Gandi & McKeigue’s 8 year follow up, (1999 unpublished, but 
presented at ‘Heart Health in Developing Countries’ conference, Delhi October 1999) 
and the other large sample in Mauritius (Tuomilehto et al 2000 – unpublished 
manuscript, personal communication. (Note publication bias here: 2 of 3 negative 
studies still unpublished). 
 
Body fat, general and early life factors 
 
However, as in any other population, critical factors underlying diabetes development 
in South Asians include: body fat accumulation whether as rising BMI (at levels as 
low as or lower than 22 kg/m2), or as a particular propensity to increased abdominal 
fat, measured as waist alone or as waist/hip or waist/thigh circumference ratios; 
energy imbalance as inadequate energy expenditure from too little general physical 
activity for given dietary intakes. Increased abdominal fat falls under the umbrella of 
another vague but highly fashionable term, the ‘metabolic syndrome’. This includes 
insulin resistance and concurrent glucose intolerance, dyslipidaemia, ‘hypertension’ 
(variably defined) and increasingly other concomitant, more recent metabolic risk 
factors. How much morbidity or mortality the syndrome per se contributes over and 
above its component risk factors is unclear. Nevertheless, the syndrome is of course 
commoner in South Asians compared with western populations18,19. Risk factors for 
developing the metabolic syndrome, in South Asians particularly, may include the use 
of ghee and the consumption of low amounts of all of the following: vitamin C, 
vitamin E, omega –3 fatty acids especially eicosapentanoic (EPA) and 
docosapentanoic (DHA), and monounsaturated fatty acids19. Lower birth weight has 
been associated with a high prevalence of the metabolic syndrome in later life20 and 
small birth dimensions are also found in South Asians compared with other ethnic 
groups, a finding that seems to persist in subsequent generations to date to date21, as 
we have found across ethnic subgroups from the subcontinent in a national dataset22. 
Low initial body size, in addition to excess catch-up growth and greater BMI during 
childhood, may increase risk of any glucose intolerance and later overt ‘diabetes’. 
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This is perhaps amongst the best-studied example of the Hales/Barker ‘thrifty 
phenotype’ hypothesis (as discussed later by Fall in chapter 5).  
 
Recently Yajnik has shown that in babies of mothers in Pune, India, insulin 
concentrations in cord blood were raised compared with that of white European 
babies born in London and were correlated with sub-scapular skinfold thicknesses23. 
His follow-up studies have also shown that later in childhood these ‘thin-fat’ Indian 
babies become more insulin resistant24, an association that is modified by postnatal 
growth: greater catch up growth results in greater insulin resistance. This needs 
further investigation if only to clarify definitions of catch up growth (length, weight, 
head circumference, central fat).  
 
Other nutritional factors 
 
The role of raised blood homocysteine (Hcy) levels among South Asians, with or 
without diabetes, is currently being investigated widely. At a molecular level, Hcy 
facilitates oxidant injury to the vascular endothelium and inhibits nitric oxide 
production, thus promoting atherosclerosis and coronary heart disease. A meta-
analysis found that Hcy concentrations that were 25% lower than average were 
associated with a lower risk of CHD (OR 0.89, 95% CI 0.89 to 0.96) and stroke (OR 
0.81, 95% 0.68 to 0.95) compared with normal Hcy concentrations25. Recent studies 
have shown that plasma Hcy concentrations are higher in adult British South Asians 
than white Europeans26, 27. Dietary supplements of folate and vitamin B12 have been 
shown to reduce plasma Hcy concentrations by up to 25%. Nutritional factors are 
likely to be important since reduced intake of vitamin B12 and folate, due to prolonged 
cooking of vegetables  (which may destroy up to 90% of folate), have been reported 
in Gujaratis28. Our own data have found very low dietary folate intakes in Indians 
living in Indian villages. Perhaps surprisingly, raised Hcy is found both in the sub-
continent itself, and in migrant people and their descendents abroad. The 
simultaneous presence of excesses of some and deficiency of other specific dietary 
fatty acids, e.g. long chain polyunsaturates such as EPA and DHA acid (as found in 
oily fish), is another continuing area of research. 
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Endothelial dysfunction, arising from oxidative damage due to glucose intolerance 
and from diets low in antioxidants or hyperhomocysteinaemia, results in an increased 
expression of inflammatory molecules such as cytokines (e.g. interleukin 6, which is 
also released from adipose tissue). Cytokines, which predict myocardial infarction in 
healthy men29, stimulate the liver to release the acute phase reactant C reactive 
protein (CRP), an inflammatory marker. CRP concentration is itself a sensitive 
predictor of first CVD events28. Based on pilot studies in Manchester, CRP levels are 
higher in Pakistanis31 and in British Gujaratis than in comparable European 
populations, with lower levels in UK African-Caribbeans31, whose CHD risk is 
lowest. Elevated CRP has also been associated with higher serum insulin and 
glycosylated haemoglobin (HbA1c) concentrations, suggesting a possible role of 
inflammation in insulin resistance and glucose intolerance32.  
 
Genetic and environmental interactions in insulin resistance 
 
Many nutritional factors and body composition changes over the life span, and how 
these factors may transmit risk across generations, remain to be explored, potentially 
with considerable importance for public health for South Asian communities. As yet, 
despite considerable searching, no geno-phenotypic clues or ‘candidate genes’ have 
been discovered to underlie the South Asian diabetes excess. In the authors’ view, this 
remains less likely than transmitted intergenerational risk (see below). 
 
1. Energy balance: In this context energy balance is critical, that is the balance 
between dietary energy consumed and metabolic energy expended, both basal and 
then that required to power physical activity. If net balance becomes positive, 
weight gain results (and generally persists, unless extra activity expends it). Very 
few studies have measured physical activity among South Asian or other ethnic 
groups, not least because reliable methods for doing so in free-living individuals 
have only recently begun to become available. The untested hypothesis is that for 
specific body sizes or weight, South Asian groups tend to have less muscle mass 
and hence less surface area on which insulin can act to dispose of (excess) dietary 
energy, even for given levels of physical activity. Apparent and real insulin 
‘resistance’ will occur. If physical activity is also lower at given levels of energy 
intake, then positive energy balance must follow, leading to weight gain. To the 
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current authors, such a hypothesis relating energy balance over the life-course 
with as yet generally lower muscle fibre number and bulk from smaller initial 
body size is much more likely a causal background to later glucose intolerance 
and CHD than inherent ‘insulin resistance’, which we would suggest is entirely 
secondary to these predisposing factors and not otherwise inherent.  
 
2. An intergenerational, non-genetic hypothesis: The intriguing sequel that logically 
follows is that inherent diabetes and CHD risk in these communities must then be 
genetic. We would point out that while a few polymorphic genetic markers have 
been identified that may be more common in South Asian populations, including 
related to factor VII clotting activity33 and to the MTFHR gene variants34, very 
few have as yet been repeatedly linked to either the ‘diabetes’ or CHD phenotype 
in any population. We would suggest the apparently inherent risk of both 
‘diabetes’ and CHD is more likely to be transmitted by intergenerational 
mechanisms due to repeated environmental exposures rather than inherent 
genomic variants. For example during pregnancy in women of relatively small 
stature, mild ‘hyperglycaemia’ and minor variations in concurrent metabolic 
factors such as specific and total fatty acid concentrations may be present as yet 
unrecognized as outside the usual range for that habitus. It is well established that 
in gestational or pre-pregnancy type 2 diabetes, levels of insulin in amniotic fluid 
are elevated, associated with increased cord blood insulin levels in the infant35. 
Such small persistent metabolic variations may well therefore transmit through 
generations due to external not genetic causes. Direct tests of these issues are 
underway in our maternal-infant studies. 
 
3. Ethnic sub-group similarity or heterogeneity: South Asians of most ethnic sub-
groups appear to be susceptible to the diabetes and CHD syndromes. Sub-groups 
include Hindu or Muslim, vegetarian or omnivore, Gujarati, Sikh, Bangladeshi or 
Pakistani or any other method of describing the religious, dietary, geographic and 
hence cultural diversity across the subcontinent and its migrants and their 
descendants abroad. However, if small initial size at birth (a universal feature to 
date compared with other western populations), relatively low muscle fibre 
number which increases little after birth, as well as lower overall muscle mass and 
variable catch-up growth, followed for those of adequate financial means by 
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generally excess dietary energy intake in later life, the underlying phenotype will 
be similar across the ethnic sub-groups. Yajnik’s23, 24 and Fall’s work, outlined 
elsewhere in this volume, illustrate the potential for these issues to apply.  
 
A critique of ‘Insulin Resistance’ 
 
Finally, it is worth examining the validity and credibility of the insulin resistance 
hypothesis for CHD, because it has been applied with such vigour to the CHD 
problem among South Asians.  Simplistically, insulin resistance can be defined as 
excess plasma insulin for given plasma glucose levels – which would be lower if 
insulin action were as effective as ‘usual’. Insulin resistance is apparently commoner 
in South Asians and as such has been floated as the major mechanism underlying the 
reported excess of both diabetes and CHD36. This suggestion has many flaws, which 
are outlined below and build on a previous comment37, including two immediate 
caveats to any such definitions of insulin resistance. These are: 
 
1. Peripheral venous blood measures: Note that to define insulin resistance, 
what is universally measured are peripheral venous plasma levels of both 
‘insulin’ and glucose, and not arterial levels. Arterial blood levels are the 
circulating concentrations that all tissues respond to apart from the liver, right 
heart, lung alveoli and their vascular endothelia, as insulin is secreted into 
pancreatic venous, flowing into portal, blood. Measuring arterial or portal 
venous blood is not widely possible, hence nor is what really influences 
peripheral blood insulin levels – insulin’s ‘first pass’ hepatic uptake, known to 
be highly variable depending on fasting or fed status, time since last meal and 
that meal’s composition etc.  
 
2. Assay specificity: a second critical technical point is how insulin is assayed. 
Most studies have measured ‘insulin’ using a traditional radioimmunoassay 
with a widely available polyclonal antibody, which has major if variable 
cross-reactivity with its pro-insulin precursor molecule. When specific 
monoclonal antibodies against ‘intact insulin’, pro-insulin and its split 
product, 32-33 split pro-insulin are used in respective assays, 10-20% of 
apparent insulin in the traditional assay is found to be these other molecules38.  
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3. Pro- and Split Pro- Insulins: Apart from the possibility that pro-insulin itself 
and 32-33 split pro-insulin may have direct toxic actions on vascular 
endothelium and beta-cells, the variable proportions of pro-insulins also likely 
compete with intact insulin at its receptor, leading to apparent ‘resistance’. 
Intriguingly, in two recent cohort analyses, when pro-insulin or 32-33 were 
measured as well as insulin, they displaced insulin itself in predicting 
diabetes39, 40. In a third, among adolescents followed from birth, pro-insulin 
levels were more closely correlated with early life indices than was insulin41. 
 
4. Problems with interpreting clamp studies: A further major problem of 
interpretation in studies of insulin resistance is physiological and comes in 
‘clamp’ studies, regarded by biochemical investigators as the gold standard 
test. By definition, physiological insulin release and its control are primarily 
driven by food intake, hence gastric filling itself and the nature of the food 
consumed (simple or more complex sugars primarily, fatty and amino acids 
etc.). Clamp studies entirely bypass this entero-hepatic circulation and their 
physiological relevance remains uncertain. 
 
5. The IGF system and its binding proteins: Key influences on sensitivity in liver 
cells to (intact) insulin in portal blood are type and quantity of fatty acids, 
which are continuously released from visceral fat but also rise substantially 
after meals, and render hepatic cellular responses much less sensitive to 
insulin (= hepatic insulin resistance). Hence recent, ‘acute’ dietary 
composition and what is derived ‘chronically’ from the diet over the longer 
term but stored as visceral fat are key effectors. In this context, other insulin-
like molecules are important, notably the insulin-like growth factors (IGF) and 
their several binding proteins (IGF-BP), themselves biologically and possibly 
vasoactive. IGF-I has insulin-like actions cross-reacting with the insulin 
receptor, while IGFBP-1, its main tissue-release modifier, is synthesized in 
non-pregnant human beings only by the liver where its release is tightly but 
negatively regulated by portal blood insulin. IGFBP-1 hence also seems to be 
closely regulated by portal blood fatty acid concentrations. Finally, there are 
major variations in serum IGF system concentrations by ethnic group as we 
  56 
have described42, and these not only relate to cardiovascular risk in cross-





This discussion illustrates the many current themes under investigation, often 
somewhat confusingly at varying points along potential causal pathways leading to 
the disease endpoints. No direct evidence as yet supports efforts specifically aimed 
just at prevention for South Asian populations. However, general measures, which are 
beginning to be found to work generally, apply even more so to any South Asian 
community, in general public health terms. 
 
Public Health action: Control of hyperglycaemia or overt diabetes is a separate topic 
but aggressive management of hyperglycaemia before diabetes is diagnosed by life 
style measures is effective in delaying and possibly preventing overt diabetes45,46. 
Importantly, lifestyle interventions for the prevention of diabetes have not been tested 
in South Asians in the UK. After formal diagnosis of diabetes, aggressive 
management of standard risk factors seems clearly indicated although some authors 
have suggested that pre-diabetes care is appropriate in South Asians47. This applies 
particularly to (high) blood pressure and lipidaemia, probably below levels accepted 
for other ethnic groups because of the increased cardiovascular risk48. 
 
These types of measures should help to contain the global public health problem of 
diabetes and its vascular sequelae in South Asian populations, even without adequate 
explanations of the excess of either condition as yet. Major research efforts are and 
need to be underway to resolve the issues, which should throw light on the aetiology 
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4 
 
Endothelial Dysfunction : Underlying 
mechanisms and their relevance for 
coronary heart disease in South Asians  
 




The endothelial cell lining of the vasculature plays a fundamental role in maintaining 
vascular homeostasis in health, through multiple actions including the release of 
bioactive molecules (e.g. nitric oxide and prostacyclin) and the expression of surface 
molecules (e.g. tissue plasminogen activator (tPA)) and enzymatic activities (e.g., 
angiotensin converting enzyme (ACE)). Nitric oxide has multiple actions in the 
vasculature, including flow-dependent vasodilatation, inhibition of leukocyte and 
platelet adhesion and aggregation, anti-proliferative and anti-apoptotic activity, and 
the inhibition of vessel permeability, which collectively tend to be anti-
atherosclerotic. Compelling evidence supports a role for endothelial cell dysfunction 
as a key early event in the pathophysiology of atherosclerosis1. The term endothelial 
dysfunction encompasses a range of potential abnormalities, among which 
abnormalities of nitric oxide bioactivity, increased production of reactive oxygen 
species and the increased expression of cell surface adhesion molecules have received 
particular attention. It is now well established that the production or bioactivity of 
nitric oxide is reduced in conditions that predispose to atherosclerosis such as 
hypercholesterolaemia, diabetes mellitus, and cigarette smoking1. Endothelial 
dysfunction is often demonstrable years before any clinical manifestation of CHD. 
Furthermore, recent studies have shown that the presence of either coronary vascular 
or forearm vascular endothelial dysfunction in subjects without evidence of CHD is a 
powerful predictor of future major cardiovascular events 2,3.  
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CHD in UK South Asians  
 
As discussed in chapter 1 by Bhopal, South Asian males have a greater CHD 
mortality than their white European counterparts4. Conventional risk factors alone do 
not account for the increased rates of CHD. Two potential reasons for the increased 
CHD rates in South Asians are an increased prevalence of novel risk factors and/or an 
increased sensitivity to conventional risk factors (i.e., an altered “dose-response” 
relationship). Environmental as well as genetic factors may be relevant to both these 
possibilities (Figure 4.1).  
 
Figure 4.1. Potential reasons for increased incidence of atherosclerotic disease in 
South Asians 
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Although the evidence is not clear cut, as pointed out by Cruickshank et al in chapter 
3, a higher prevalence of the metabolic syndrome (in particular the components of 
glucose intolerance and hyperinsulinaemia) may account for some of the excess CHD 
rates in South Asians5,6. Consonant with this, it has been shown that South Asian 
males are more insulin resistant than age-matched white European males, independent 
of generalised or truncal obesity7. Some of the reasons for the increased prevalence of 
insulin resistance may include reduced levels of physical activity and possibly 
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amplified metabolic responses to particular diets, e.g. those high in carbohydrates8. 
For example, it has been shown that plasma insulin levels correlate closely with 
carbohydrate intake in South Asians9.  
  
An increased “dose-response” relationship to insulin resistance is suggested by 
findings such as the observation that South Asians with diabetes have CHD mortality 
rates higher than matched white European diabetics10. These data raise the intriguing 
possibility that the vasculature of South Asians and in particular younger South Asian 
males may be more susceptible to atherosclerosis when faced with components of the 
insulin resistance syndrome. In keeping with this, epidemiological studies looking at 
the relationship between carotid intima-media thickness and CHD prevalence in 
different ethnic populations have also suggested the possibility of a steeper “risk load-
response” relationship in South Asians11. 
 
The link between insulin resistance, endothelial dysfunction and atherosclerosis 
 
Insulin resistance is defined as resistance to the glucoregulatory actions of insulin. 
The underlying abnormality is thought to lie at one or more sites along the pathway 
linking the insulin receptor on the cell membrane to stimulation of glucose uptake via 
insulin-sensitive GLUT-4 membrane glucose transporters in the cell membrane12. A 
fundamental consequence of insulin resistance is fasting and postprandial 
hyperinsulinaemia, one effect of which is to stimulate hepatic triglyceride release. 
Resistance to the antilipolytic action of insulin increases the flux of non-esterified 
fatty acids (NEFAs), which augments the rise in triglyceride levels. Elevation of 
triglycerides and NEFAs are thus additional hallmarks of insulin resistance. NEFAs 
may further aggravate insulin resistance because of their effect to inhibit both glucose 
transport and key enzymes of glucose metabolism in skeletal muscle13. 
  
Hyperinsulinaemia, a contested risk factor per se, has been demonstrated to be an 
independent risk factor for the development of CHD, the magnitude of risk being of 
the same order as that of the well established risk factor of hypercholesterolaemia14,15. 
The IRAS study group demonstrated that insulin sensitivity is inversely proportional 
to the extent of atherosclerosis16. It is well established that the natural history of type 
2 diabetes is often an insidious progression from insulin resistance with 
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normoglycaemia to pancreatic decompensation and loss of glucose homeostasis. It is 
also likely that vascular disease in type 2 diabetes occurs before the onset of 
hyperglycaemia17.  
  
At least part of the increased atherogenic risk associated with insulin resistance may 
involve the development of endothelial dysfunction. Insulin resistance is associated 
with vascular endothelial dysfunction in humans18, and there is a close correlation 
between insulin sensitivity and basal nitric oxide production in healthy subjects19. 
Insulin resistant non-diabetic relatives of patients with type 2 diabetes have impaired 
flow-dependent vasodilator responses (a surrogate marker of endothelial dysfunction), 
implying a reduction in nitric oxide bioavailability20. Flow-mediated vasodilatation is 
also impaired in young South Asian males in comparison to age-matched white 
Europeans, independent of body mass index, cholesterol and HDL levels21. Evidence 
from animal studies also supports a causal relationship between insulin resistance and 
endothelial dysfunction22.  
  
Another aspect of endothelial function that may be implicated in the increased 
atherosclerotic risk associated with insulin resistance is the expression of adhesion 
molecules such as VCAM-1 and ICAM-1. Circulating levels of these adhesion 
molecules have a close and independent correlation with insulin resistance in healthy 
subjects23. Furthermore, recent evidence suggests that  CRP, the concentration of 
which is inversely proportional to insulin sensitivity24, is an independent risk factor 
for the development of atherosclerosis. This may involve the stimulation of adhesion 
molecule expression by vascular endothelial cells. Interestingly, C-reactive protein 
(CRP) has been shown to have several direct effects on endothelial cells including 
changes in nitric oxide synthase expression level.  
 
Potential mechanisms underlying the relationship between insulin resistance and 
impaired NO bioactivity  
 
Endothelial nitric oxide is generated from the amino acid L-arginine by the 
endothelial nitric oxide synthase enzyme (eNOS) in a reaction which requires 
tetrahydrobiopterin (BH4) as a co-factor1. In general, a reduced bioactivity of 
endothelium-derived nitric oxide results from a reduced expression of eNOS, reduced 
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activation of eNOS and/or the increased inactivation of nitric oxide by reactive 
oxygen species. The balance between nitric oxide production, reactive oxygen species 
production and antioxidant balance is increasingly recognized as key to endothelial 
homeostasis. Indeed, in subjects with endothelial dysfunction, a recent study showed 
that the presence of oxidative stress was a powerful independent predictor of future 
cardiovascular events3. 
 
In patients at high risk of developing CHD, a reduction in nitric oxide bioactivity is 
easily demonstrable in vivo, for example by impaired flow-mediated endothelial-
dependent vasodilatation in the forearm or coronary vascular beds. Recent advances 
in endothelial biology indicate that these two responses reflect different subcellular 
mechanisms of eNOS activation and, importantly, may be differentially affected by 
insulin resistance. Whereas eNOS activation by agonists such as acetylcholine is 
calcium (Ca2+) dependent, its sustained activation by shear stress involves the activation 
of PI3-kinase and then protein kinase B (or Akt) which causes eNOS phosphorylation25,26. 
The latter increases eNOS activity and its sensitivity to Ca2+, so that it becomes active at 
subphysiological Ca2+ concentrations. Interestingly, the ‘PI3-kinase / Akt pathway’ is one of 
the primary subcellular pathways activated by insulin in many cell types, and has been shown 
to malfunction in cases of insulin resistance12. Furthermore, insulin is a vasodilator27 that acts 
at least in part via the activation of PI3-kinase and Akt, leading to endothelial nitric oxide 
release28. An abnormality of the PI3-kinase / Akt pathway in the endothelium of insulin 
resistant subjects could therefore potentially contribute to endothelial dysfunction, particularly 
in response to increased blood flow or shear stress. Indeed, the vasodilator effect of insulin is 
blunted in insulin resistant humans29. Likewise, there is selective impairment of PI3-kinase-
dependent Akt phosphorylation in isolated vessels of insulin resistant rats30. 
 
There is also evidence for the alternative mechanism of endothelial dysfunction, 
namely increased reactive oxygen species production, in insulin resistant states both 
experimentally and in patients. Recent studies indicate that major sources of reactive 
oxygen species that may contribute to endothelial dysfunction include dysfunctional nitric 
oxide synthases and phagocyte-type NADPH oxidases, both enzymes that can be regulated 
by pathophysiological stimuli implicated in the metabolic syndrome 1,31,32.  
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The role of obesity  
 
Obesity increases the risk of developing cardiovascular atherosclerosis33 and South 
Asians are known to have high rates of visceral adiposity relative to overall BMI as 
discussed in earlier chapters. The association between obesity and endothelial 
dysfunction is well established, both in animal studies and in man34. While a 
significant component of the increased risk associated with obesity may be related to 
the presence of insulin resistance, recent data indicate the additional possibility of 
alternative mechanisms. In particular, it has become evident that the adipocyte is not 
simply a fat storage cell but also an endocrine organ that releases bioactive proteins 
(“adipokines”) in response to specific extracellular stimuli or perturbations in 
metabolic status. These adipokines include leptin, TNF-α and angiotensin II, all of 
which may potentially influence endothelial function and promote atherogenesis. 
Indeed, plasma levels of these adipokines are well established as being significantly 
elevated in obese humans. Thus, detailed studies here are also required to establish the 




The thesis advanced in this article is that the increased risk of CHD in UK South 
Asians may be related both to a higher prevalence of metabolic dysregulation (insulin 
resistance and visceral obesity) and to an increased impact of the metabolic syndrome 
on the vasculature. Central to the ways in which metabolic dysregulation leads to 
atherosclerosis may be the role of endothelial dysfunction and activation. 
Investigation of the mechanistic relationship between insulin resistance, obesity, 
vascular dysfunction and atherosclerosis, both in white Europeans and South Asians, 
will be valuable in defining the basis for the increased CHD rates in South Asians and 
providing novel therapeutic targets. In addition, the reasons for the increased prevalence of 
metabolic syndrome per se in South Asians require elucidation. Both genetic and 
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5 
 
Fetal and early life origins of 




Introduction - the fetal origins hypothesis 
 
Studies based on the follow-up of men and women whose birth weights were 
recorded have shown that poor fetal growth, indicated by a low weight at birth, is 
associated with an increased risk of adult cardiovascular disease (CVD). Some 
classical risk factors for CVD, including the metabolic syndrome and its component 
features - hypertension, type 2 diabetes, insulin resistance, truncal obesity, and 
dyslipidaemia also show associations with low birthweight. The fetal origins of adult 
disease (FOAD) hypothesis proposes that these reflect 'programming', whereby 
transient events, in this case fetal undernutrition, occurring at critical stages of 
development, have long-term effects on the body's structure and function1. Fetal 
adaptations to undernutrition, to conserve nutrients and prioritise brain growth, 
include reduced secretion of and sensitivity to the fetal growth hormones insulin and 
IGF-I (insulin like growth factor –type 1), altered body composition (reduced muscle 
growth), and impaired development of some abdominal organs (reduced renal 
nephron numbers and pancreatic beta cells). The glucocorticoid system is up-
regulated. According to the FOAD hypothesis these changes have permanent 
metabolic effects that lead to later disease. An alternative hypothesis is that both low 
birth weight and adult disease have common genetic antecedents.  
 
The effects of low birthweight on later CVD risk are modified by the pattern of post-
natal growth. Although greater weight gain in infancy (the first 12 post-natal months) 
is associated with a reduced CVD risk, the reverse is true for weight gain (and fat 
gain) during childhood, adolescence and adult life, all of which are associated with an 
increased risk. Childhood and adult BMI interact with size at birth. The adverse 
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effects of obesity on cardiovascular risk are greatest in people who were small at 
birth2.  The effects of this mis-match between fetal ‘thrift’ and post-natal ‘plenty’ has 
been called ‘adaptation-dysadaptation’.  
 
Recent studies indicate that in addition to the adverse effects of low birthweight, there 
are problems at very high birthweights. Offspring of mothers with gestational 
diabetes, which causes fetal overnutrition (macrosomia) have an increased risk of 
obesity and type 2 diabetes compared with offspring of non-diabetic mothers or 
women who became diabetic after the pregnancy. There is therefore a U-shaped or J-
shaped relationship between birthweight and adult type 2 diabetes, with increased 
rates of disease at both low and very high birthweights3. 
 
An explanation for CVD in South Asians? 
 
Poor fetal growth may contribute to the current epidemic of CVD occurring in South 
Asian populations. CVD in South Asians is often associated with insulin resistance 
and the metabolic syndrome, the risk factors which have been consistently linked with 
low birthweight. Mean birthweight in the Indian subcontinent is 2.6-2.8 kg, the lowest 
in the world, and remains low in UK South Asians. Poor weight gain in infancy is 
also common. At the same time, recent improvements in nutrition, resulting from 
urbanisation or migration abroad, enable small babies to catch-up. Both childhood 
and adolescent obesity are rapidly emerging problems. Increasing numbers of South 
Asians are therefore making the ‘high-risk’ journey from intrauterine nutritional 
poverty to post-natal nutritional affluence. There are few data from India on the 
prevalence of gestational diabetes, but studies of South Asian migrants to the UK and 
elsewhere have shown rates of gestational diabetes approximately 5 times those of the 
white European population.  
 
FOAD research in India 
 
Studies designed to test the FOAD hypothesis have been carried out in India at the 
KEM Hospital, Pune (children) and Holdsworth Memorial Hospital, Mysore (adults) 
using birth data recorded in obstetric notes. In Pune, low birthweight children (at 8 
years) had increased blood pressure, LDL-cholesterol concentrations and 
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subscapular/triceps skinfold ratios4, and those with a high childhood weight and fat 
mass also had raised plasma insulin (Figure 5.1) and IGF-I concentrations and urinary 
glucocorticoid excretion. In Mysore, among 20-40 year old adults, lower birthweight 
was associated with impaired glucose tolerance, higher plasma insulin and 
triglyceride concentrations and ischaemic ECG changes5. Among older adults (40-60 
years), there were associations between low birthweight and clinical coronary heart 
disease and insulin resistance (Figure 5.2)6,7. In this older age group the findings for 
type 2 diabetes differed from the younger men and women. Diabetes occurred more 
commonly in those who were heavy relative to their length at birth (high ponderal 
index, birthweight/length3), and whose mothers were heaviest during pregnancy7. 
This may reflect gestational diabetes.     
 
Determinants of low birthweight in South Asians 
 
Size at birth is determined by both genes and environment. The mother’s nutritional 
status is one of the most important modifiable factors. Nutrition throughout the life 
cycle of a female influences the fetal growth of her offspring. Studies of 
contemporary pregnancies in Pune and Mysore showed that the mother's fat mass (a 
measure of her current nutrition), her height and head circumference (her childhood 
growth) and her birthweight (her own fetal growth) all predicted the birthweight of 
her offspring8. Genetic effects, indicated by correlations between paternal size and 
offspring birthweight were significant, but weaker than maternal effects, and related 
mainly to fetal skeletal growth (length and head size). In the Indian neonates, non-fat 
soft tissues (muscle and abdominal circumference) were reduced by about two 
standard deviation scores compared with UK white European babies, but body fat 
(skinfold thickness) was relatively preserved9. The well-known propensity of South 
Asian populations for central obesity thus appears to be present at birth. Neonatal 
body fat correlated with the mother's body fat, plasma glucose and triglyceride 
concentrations.  
 
Neonatal size was also related to maternal diet. In a rural area near Pune (the Pune 
Maternal Nutrition Study) mothers with higher intakes of green leafy vegetables 
(GLVs), fruit and milk and higher red cell folate and plasma vitamin C concentrations 
had babies that were larger in all measurements at birth10. Birth size was not related to  
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maternal energy or protein intakes. These data suggest that micronutrients, for which 
GLVs, fruit and milk are rich sources, may be important limiting factors for fetal 
growth in this undernourished population (mean maternal BMI 18 kg/m2). This is 
currently being tested in a food supplementation study in Mumbai. Another factor in 
the rural population was maternal physical workload. Mothers with higher energy 
expenditure, determined using a workload questionnaire, had smaller babies11. There 
were striking associations between the most strenuous activities, such as carrying 
water from the well, and hand-washing clothes, and lower birthweight. The factors 
responsible for persisting low birthweights among UK South Asians must be quite 
different; however, effects of the mother’s own fetal experience on her capacity to 
nourish her fetus may lead to a delay of at least one generation before nutritional 
improvements in any population lead to substantial gains in fetal growth. 
 
The prevalence of gestational diabetes was low (0.2%) in the rural Pune population, 
but high (6%) among urban mothers in Mysore12. The relative adiposity of the Indian 
neonate was exaggerated further in babies of diabetic mothers. Future studies are 
under way to examine effects of maternal diet and gestational diabetes, and childhood 
growth patterns, on the development of CVD risk.  
 
Two new cohort studies of young adults in New Delhi and Vellore, are currently 
taking place, funded by the British Heart Foundation. Numbering around 2,000 in 
each centre these unique cohorts have exceptionally detailed data from before 
pregnancy (maternal and paternal height and weight), at birth (birthweight, birth 
length, head circumference, accurate gestational age) and throughout childhood 
(weight, height and head size during infancy, childhood and adolescence). A range of 
CVD risk factors are being measured and these studies will be particularly helpful in 
determining how post-natal growth affects the risk of adult disease. 
 
Implications for prevention of disease and future research 
 
Cardiovascular disease and type 2 diabetes have reached ‘epidemic’ proportions in 
South Asian populations. If fetal nutrition is an important factor in their aetiology, 
preventive measures will need to focus on improvements in fetal growth and 
development, as well as on adult lifestyles. Better nutrition of girls and of young 
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women before and during pregnancy are obvious recommendations for South Asian 
populations still suffering from overt undernutrition. It is not clear, however, how to 
improve fetal development in mothers who may have experienced undernutrition in 
their own fetal life and childhood, and who are stunted, but who are well-nourished as 
adult women. Indeed there are risks if they become overnourished; they should 
certainly avoid frank obesity, which carries an increased risk of gestational diabetes, 
and increases body fat in the fetus. More research is needed into the effects of the 
mother’s dietary quality on fetal growth. While few women in the UK are lacking 
sufficient dietary energy and protein, their micronutrient status is often less than ideal, 
especially in lower income families who cannot afford fresh vegetables and dairy 
products. This is true in all ethnic groups, not just South Asians.  
 
Avoidance of obesity in childhood is important for many reasons and in all ethnic 
groups. The imperative is probably even greater for South Asian children. The 
relative adiposity of South Asians means that at any level of BMI, they have a higher 
fat mass than other ethnic groups. Increased risk for later disease starts at lower levels 
of BMI, indeed at BMI levels which would not be considered obese by UK standards. 
These risks are greater still for the individual who started out as small-for-dates 
babies. Type 2 diabetes, previously considered an adult disease, is already appearing 
among children in the UK, especially South Asian children. Prevention of childhood 
obesity, and promotion of physical activity in children, needs to go out as a very 
strong public health message, and as a matter of urgency, to South Asian families.  
 
Opportunities to study fetal and early life determinants of CVD in UK South Asians 
are limited by a paucity of good quality longitudinal data for mothers, neonates and 
children.  There is a need for birth cohorts from all ethnic groups to be established 
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6 
 
Coronary heart disease in South Asian 
populations - the role of genetics  
 
 




As discussed previously, the only logical explanation to account for the increase in 
CHD in South Asians arising from urbanization or migration is that it is a reaction to 
an adverse environment. Clearly, given the short time span involved in the emergence 
of the epidemic, genetic factors cannot solely be responsible and this has led to a 
minimization of their importance in most reviews. We propose here that elucidation 
of the genetic factors that predispose to CHD in South Asians is central to a fuller 
understanding of the epidemic and the nature of gene-environment interactions in the 
aetiology of CHD. Given this potential, we highlight the paucity of studies on 
genetics of CHD in South Asians and the relative lack of inclusion of South Asians in 
ongoing or planned genetic epidemiological studies and discuss the reasons behind 
this. We highlight the urgent need to address and rectify this deficit. 
 
CHD has an important genetic contribution, especially in its more premature form. 
Thus, family studies in white European subjects have shown that a history of CHD 
before the age of 55 years in a 1st degree relative increases the risk in an individual by 
up to 10 fold1. This applies equally to subjects originating from South Asia. Francke 
et al2 report a 7.4-fold increased prevalence in siblings of Mauritian Asians affected 
by CHD.  
 
Another epidemiological observation that highlights the likely importance of genetic 
factors is the striking contrast in incidence of CHD in different ethnic groups e.g. 
higher rates of CHD in South Asians compared to Afro-Caribbean and Chinese 
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populations 3,4 (also see Table 1.1A in chapter by Bhopal). These differences cannot 
be fully accounted for by conventional risk factors alone and suggests a role for 
genetic factors in determining the prevalence of disease. 
 
The last decade has seen significant efforts attempting to elucidate the genetic basis of 
CHD. The main approach used has been a case-control design5 where the frequency 
of a candidate gene variant in subjects with a specified CHD phenotype is compared 
with those without such a phenotype. Variants in several genes involved in lipid 
metabolism, thrombosis and vascular biology have been associated with risk of 
myocardial infarction or other CHD phenotypes6. A major issue that has limited 
application of the data has been inconsistent replication of primary findings in 
subsequent studies6. Important contributory factors to this include the low power of 
many studies, varying definitions of the phenotype, genetic heterogeneity between the 
populations studied, and a likely major modulating impact of gene-environment 
interactions5,6. Nonetheless, a role for several gene variants now seems highly 
probable with similar findings across multiple studies, supported by findings in 
prospective studies and in “meta-analyses” 6. More recently, results of family-based 
genetic approaches are beginning to emerge in the CHD field2,7,8. The most common 
approach that has been adopted has been the affected sib-pair approach where large 
numbers of families with more than one affected sibling are analysed using 
anonymous genetic markers to identify regions of the genome that are shared more 
commonly than by chance by the affected siblings5. These regions are thus likely to 
contain either a single gene or multiple genes that affect the risk of CHD in a 
proportion of the families. The advantages of the linkage approach are first, that there 
is no a priori assumption of the likely nature of the gene(s) involved and second that 
the whole genome can be screened. The disadvantages are that the studies need large 
number of individuals to obtain adequate power to detect modest effects and when 
linkages are identified there is a still considerable effort required to identify the causal 
gene and variant within the region5. The most persuasive example of this approach to 
date in CHD has been a mapping of a locus on chromosome 14 in 513 white 
European families which was associated with an increased risk of myocardial 
infarction7. Interestingly, one of the first genome-wide search for loci predisposing to 
CHD has been conducted in a South Asian origin population – Indo-Mauritians – who 
are known to have a prevalence of CHD which is amongst the highest in the world2. 
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99 independent families of North Eastern Indian origin were recruited for a genome 
scan using 403 microsatellite markers. The proband was required to be affected at a 
young age (<52 years) in an attempt to further enhance the genetic contribution to 
their disease. Suggestive linkage for CHD was obtained for regions on chromosome 
16p13-pter and 10q23. This region partially overlapped with a linkage peak for 
hypertension.  
 
Having provided a brief review of the genetic approaches to CHD, the main purpose 
of this paper is not to tabulate and review the few genetic studies that have been done 
on CHD  in South Asians but to consider potential underlying genetic explanations 
for the increased incidence of CHD in South Asian subjects compared with other 
ethnic groups. 
 
Theoretically, at least, there are 3 possibilities (Table 6.1). First, that there are gene 
variants that are specific and exclusive to South Asians that increase their risk. There 
is little epidemiological or genetic evidence to support this so this explanation seems 
unlikely. Second, certain risk alleles may be more prevalent in South Asians 
compared to other ethnic groups. These variations in prevalence may be due to 
chance or more likely a consequence of evolutionary advantage that they provided at 
some stage in the divergence of ethnic groups. The “thrifty gene” hypothesis initially 
proposed by James van Gundia Neel  falls into this category9.  Simply put, this much-
debated hypothesis proposes that there are genetic variants that were protective and 
enhanced survival at a time when calories and salt were less abundant, but harmful in 
the presence of increased caloric intake9. Such alleles could be more common in 
South Asians and predispose to central obesity and diabetes mellitus, which are 
important predisposing factors for CHD in these subjects10. Interestingly, Davey and 
colleagues11 have shown that central fat distribution is highly heritable in South Asian 
families. In trying to identify genetic variants that may underlie the “thrifty gene” 
hypothesis the focus has rightly been on genes and pathways involved in the insulin 
resistance metabolic syndrome12 (also see Chapter 2). However, the nature of the 
genetic pathways remain unclear. There is emerging evidence that functional or 
function-associated variants in other cardiovascular genes show significant inter-
ethnic variations. For example, the D allele of the angiotensin converting enzyme 
(ACE), which is associated with higher plasma ACE levels is less common in South 
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Asians subjects than in white Europeans or people of African origin13.   Lipoprotein 
(a) (Lp[a]) is another genetically determined risk factor for CHD, especially when 
accompanied by increased concentrations of LDL14. Some studies have shown that 
South Asians have higher plasma levels of Lp[a], whether living in the United 
Kingdom or in Punjab, compared to white European subjects15, presumably due to a 
higher prevalence of variants in the apolipoprotein (a) gene that increase Lp[a]14. The 
capacity of a migrating population to rapidly acquire a raised LDL cholesterol level 
due to changes in dietary patterns and/or life-style shows how a genetically 
determined CHD risk factor – increased Lp[a] – can be transformed into a more 
potent risk factor by westernization16. This example emphasises the importance of 
considering the role of genetics if we are to fully understand the epidemic of CHD in 
South Asians. It illustrates, the concept of gene-environment interactions (the third of 
the possible scenarios illustrated in Table 6.1), which must ultimately determine CHD 
risk.  It is important to recognise that variation in risk may occur where the frequency 
of disease associated alleles is similar in different ethnic groups but the exposure to 
the relevant environmental risk factor varies. Possible environmental risk factors that 
may differ between ethnic groups include those related to diet, physical activity, 
smoking and those that are less easy to quantify such as stress. The point is that 
emphasising either environmental factors or genetic factors alone produces an 
incomplete picture. 
 
We propose that identifying differences in inter-ethnic prevalence of functional 
variants in key cardiovascular system (CVS) pathways and understanding their 
impact on intermediary phenotypes in particular environmental settings provides a 
powerful and efficient strategy to dissecting the genetic basis of complex traits 
(Figure 6.1).  
 
Table 6.1. Possible genetic explanations for increased risk of coronary heart 
disease in South Asians 
 
1. Disease-related mutations specific to South Asian populations  
 2. Increased prevalence of susceptibility alleles 
 3. Adverse gene-environment interactions 
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Figure 6.1: Use of inter-ethnic differences in functional genetic variants to 
dissect the genetic basis of coronary heart disease 
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Given this potential, it is noteworthy that few genetic studies in CHD have been done 
in subjects of South Asian origin and indeed many of the large genetic projects in 
Western counties have specifically excluded non-white subjects17. Although the 
immediate rationale for this is understandable, namely to optimise power and try and 
minimize genetic heterogeneity and population stratification as a cause of misleading 
(false positive) findings5, future projects need to consider the gains to be had, 
especially in studies focusing on functional variants and intermediary biochemical or 
physiological phenotypes on the causal pathway to disease. However, even where 
participation is open to all communities, uptake by ethnic minority groups and 
particularly South Asian groups is low. For example, in the BHF Family Heart Study, 
less than 2% of the over 2000 families recruited come from a South Asian 
background despite a concentration of recruitment effort in areas with large South 
Asian communities (NJ Samani, unpublished data). The reasons behind the low 
participation of ethnic minority groups in genetic studies need to be identified and 
addressed. The information provided may be insensitive to issues of culture and 
religion, as well as language. Benefits of participation may not be clear. In addition, 
the word ‘genetic’ may have perceived consequences to families with regard to 
stigma within a relatively closed community. Whether some of these factors could be 
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overcome by better and more culturally specific information sensitive to religious 
concerns requires to be investigated. Especially, with major long-term projects such 
as UK Biobank18 about to start, it is important that barriers to participation of ethnic 
minority groups in genetic research are overcome so that we can fully gain from 
understanding the gene-environment interactions that underlie inter-ethnic variation 




 Genetics plays an important role in the pathogenesis of CHD in South Asians as it 
does in other ethnic groups. The epidemic of CHD in South Asians as a consequence 
of migration and/or westernisation is likely to have its root in adverse gene-
environment interactions. Elucidation of the genetic factors that predispose to CHD in 
South Asians is essential if we are to fully understand its nature and devise 








1. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic 
susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 
1988; 318:727-732. 
2. Francke S, Manraj M, Lacquemant C, Lecoeur C, Lepretre F, Passa P, Hebe A, 
Corset L, Yan SLK, Lahmidi S, Jankee S, Gunness TK, Ramjuttun US, Balgobin V, 
Dina C, Froguel P. A genome-wide scan for coronary heart disease suggests in Indo-
Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with 
the metabolic syndrome. Hum Mol Genet 2001; 24:2751-2765. 
3. Chaturvedi N. Ethnic differences in cardiovascular disease. Heart 2003; 89:681-
686. 
4. Wild S, McKeigue P. Cross sectional analysis of mortality by country of birth in 
England and Wales, 1970-92. BMJ 1997; 314:705-709. 
  86 
5. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994; 265: 
2037-2048. 
6. Samani NJ, Singh R. Molecular genetics of acute coronary syndromes. In: 
Current challenges in acute coronary syndromes. De Bono DP, Sobel E (eds). 
Blackwell Science, Oxford, 2001: 81-98. 
7. Broeckel U, Hengstenberg C, Mayer B, Holmer S, Martin LJ, Comuzzie AG, 
Blangero J, Nurnberg P, Reis A, Riegger GA, Jacob HJ, Schunkert H. A 
comprehensive linkage analysis for myocardial infarction and its related risk factors. 
Nature Genetics 2002; 30:210-214. 
8. Harrap SB, Zammit KS, Wong ZY, Williams FM, Bahlo M, Tonkin AM, 
Anderson ST. Genome-wide linkage analysis of the acute coronary syndrome 
suggests a locus on chromosome 2. Arterioscler Thromb Vasc Biol. 2002; 22:874-
878. 
9. Neel JV, Weder AB, Julius S. Type II diabetes, essential hypertension, and 
obesity as "syndromes of impaired genetic homeostasis": the "thrifty genotype" 
hypothesis enters the 21st century. Perspect Biol Med. 1998; 42:44-74. 
10. MeKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin 
resistance with high diabetes prevalence and cardiovascular risk in South Asians. 
Lancet 1991; 337:382-386. 
11. Davey G, Ramachandran A, Snehalatha C, Hitman GA, McKeigue PM. 
Familial aggregation of central obesity in Southern Indians. Int J Obes Relat Metab 
Disord. 2000; 24:1523-1527. 
12. Groop L. Genetics of the metabolic syndrome. Br J Nutr 2000;83 Suppl 1:S39-
S48. 
13. Sagnella GA, Rothwell MJ, Onipinla AK, Wicks PD, Cook DG, Cappuccio FP. 
A population study of ethnic variations in the angiotensin-converting enzyme I/D 
polymorphism: relationships with gender, hypertension and impaired glucose 
metabolism. J Hypertens 1999; 17:657-664. 
14. Editorial. Lipoprotein (a). Lancet 1991; 331:397-398. 
15. Bhatnagar D, Anand IS, Durrington PN, Patel DJ, Wander GS, Mackness MI, 
Creed F, Tomenson B, Chandrashekhar Y, Winterbotham M, Britt RP, Keil JE, 
Sutton GC. Coronary risk factors in people from the Indian subcontinent living in 
West London and their siblings in India. Lancet 1995; 345:405-409. 
  87 
16. Williams B. Westernised Asians and cardiovascular disease: nature or nurture? 
Lancet 1995; 345:410-402. 
17. Caulfield M, Munroe P, Pembroke J, Samani N, Dominiczak A, Brown M, 
Benjamin N, Webster J, Ratcliffe P, O'Shea S, Papp J, Taylor E, Dobson R, Knight J, 
Newhouse S, Hooper J, Lee W, Brain N, Clayton D, Lathrop GM, Farrall M, Connell 
J.  MRC British Genetics of Hypertension Study. Genome-wide mapping of human 
loci for essential hypertension. Lancet 2003; 361:2118-2123. 
18. UK Biobank: http://www.ukbiobank.ac.uk. 
 
 
  88 
7 
 
Inflammation and infection in 







Coronary heart disease continues to be the commonest cause of death in the 
industrialised world and is ever-increasing in developing countries1. As discussed in 
earlier chapters, conventional risk factors for atherosclerosis and CHD (such as 
tobacco smoking, diabetes mellitus, hyperlipidaemia and hypertension) are well 
recognised but fail to fully account for the varying prevalence and severity of disease, 
in different populations2. A number of potential ‘novel’ atherogenic markers have 
been proposed in recent years; infection with common micro-organisms may be one 
such risk factor which will be the focus in this chapter (Table 7.1)3,4. Atherosclerosis 
is an inflammatory disease5. At each stage through atherogenesis, including mature 
lesion development, plaque rupture and presentation with acute clinical events, 
inflammation plays a pivotal role. Serum CRP, a non-specific marker of 
inflammation, has also been found to be closely associated with cardiovascular risk 
and subsequent events – and may be a potent marker in South Asians6.  
 
Whether antigens of infective micro-organisms are an additional ‘signal’ for the 
inflammation is an intriguing and feasible possibility – but as yet proven. Many 
micro-organisms have been associated with atherosclerosis (see table 7.1). Chlamydia 
pneumoniae has emerged as the most likely ‘culprit’ pathogen of all to have a causal 
role in atherosclerosis4. For this reason, this chapter focuses on this micro-organism, 
but the difficulties shown in demonstrating cause and effect are indicative of findings 
in other micro-organisms. It is a gram-negative, obligate intracellular pathogen,  
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Author and Year of Publication 
 
Bacillus typhosus 1889, Gilbert and Lion 
Streptococci 1931, Benson et al 
Coxsackie B virus 1968, Sohal et al 
Adenovirus 1973, Fabricant et al 
Mycoplasma gallisepticum 1973, Clyde and Thomas 
Marek’s disease virus 1978, Fabricant et al 
Cytomegalovirus 1987, Petrie et al 
Herpes simplex virus 1987, Hajjar et al 
Chlamydia pneumoniae 1988, Saikku et al 
Measles virus 1990, Csonka et al 
Epstein-Barr virus 1993, Straka et al 
Human immunodeficiency virus 1993, Paton et al 
Helicobacter pylori 1994, Mendall et al 
Mycoplasma fermentans 1996, Ong et al 
Coxiella burnetti 1999, Lovey et al 
Porphyromonas gingivalis 1999, Chiu et al 
Streptococcus sanguis 1999, Chiu et al 
Actinobacillus 
actinomycetemcomitans 
2000, Haraszthy et al 
Bacteroides forsythus 2000, Haraszthy et al 
Hepatitis A virus 2000, Zhu et al 
Influenza virus 2000, Naghavi et al 
Prevotella intermedia 2000, Haraszthy et al 
 
primarily causing respiratory symptoms and complications in adults, and accounts for 
5-20% of all cases of community acquired pneumonias7. Infection with C. 
pneumoniae is usually benign but is a global phenomenon – with a seroprevalence of 
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50-70% in middle aged and older adults, irrespective of social class and geographical 
population8. 
 
Chlamydia pneumoniae and atherosclerosis 
 
The evidence implicating C pneumoniae in atherosclerosis could be subdivided into 
the following areas of investigation:  
1. Seroepidemiological data 
2. Direct identification of the micro-organism within plaque 
3. Animal models showing induction or acceleration of atherosclerosis 
4. Infection triggering pro-atherogenic and pro-thrombotic responses in various cells 
5. Preliminary anti-chlamydial antibiotic studies in humans 
 
Seroepidemiological data   
Saikku et al in 1988 were the first to demonstrate that elevated serological markers of                      
C pneumoniae infection were positively associated with CHD9. Since the original 
publication, some 80 subsequent studies worldwide have now been reported10. 
Furthermore, an association between antibodies to C pneumoniae and atherosclerosis 
in arterial sites (other than the coronary arteries) has also been reported3. Both 
positive and negative11 correlations between increasing antibody titres and presence 
and severity of atherosclerotic disease have been published. The lack of a 
standardised microimmunofluorescence test, a variable cut-off titre defining 
seropositivity, and incomplete adjustment for confounding factors may explain the 
lack of correlation seen with the larger prospective antibody studies12.  
 
Plaque studies 
In 1992, Shor et al first detected C pneumoniae in atherosclerotic lesions of the 
coronary arteries at an autopsy study13. More than 100 subsequent pathological 
specimen studies have since demonstrated C pneumoniae in a wide variety of arterial 
specimens, including occluded bypass grafts3, using techniques of 
immunocytochemistry, polymerase chain reaction and electron microscopy. Overall, 
the detection rate of C pneumoniae is approximately 60% in atherosclerotic lesions, 
versus 3% in control (non-atherosclerotic) arterial specimens3,14.  
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Chlamydia pneumoniae has also been identified in human non-cardiovascular tissue – 
such has lung, liver, spleen, bone marrow and lymph node – reflecting its ubiquitous 
presence15. The mere presence of the micro-organism in atherosclerotic lesions does 
not necessarily infer a direct pathogenetic role. The ‘innocent bystander’ hypothesis 
supports the notion that C pneumoniae could merely be carried by circulatory 
monocytes from the site of infection to remain dormant in various tissues. However a 
report by Jackson et al has shown that C pneumoniae detection rate was between              
29-50% in cardiovascular tissue versus 5-13% in non-cardiovascular tissue15. Such 
findings could be interpreted as refuting the ‘innocent bystander’ notion. There are 
only a few reports of negative pathological specimen studies and the micro-organism 
is very rarely found in ‘normal’ segments of arterial specimens16. Perhaps to a greater 
significance live ‘viable’ micro-organisms can now be cultured from plaque17,18 and 
this adds weight to a direct pathogenetic role. 
 
Infection-induced atherosclerosis in animals 
Elegant animal experiments in the 1970’s demonstrated herpesvirus-induced 
atherogenesis19. Analogous to this, Fong et al and colleagues infected rabbits 
intranasally with C pneumoniae20. The animals developed atheromatous changes in 
the aortic wall. Cholesterol supplementation in such infected rabbits increases intimal 
thickening whilst lesion thickness has been shown to be less marked in infected 
rabbits given azithromycin, an antibiotic which is active against C pneumoniae21. 
Animal models have shown the pathogenetic role in terms of temporal sequence and 
infective dose of infection and subsequent development of lesions. To what extent the 
pathophysiology and ‘acutely induced’ atherogenesis (i.e. within weeks) in laboratory 
animals reflects chronic human atherosclerosis remains to be clarified.  
 
Pro-thrombotic and pro-inflammatory mechanisms  
Laboratory based studies have shown that C pneumoniae organisms infect and 
proliferate in cells such as macrophages, endothelial cells and smooth muscle cells, 
which form the main constituents of the atherosclerotic plaque22-24. Infection may 
contribute to endothelial dysfunction and lead to the expression of inflammatory 
markers such as fibrinogen, CRP, cytokines, chemokines and adhesion molecules22. 
Several of these markers are potential predictors for first and future cardiovascular 
events. Chlamydia pneumoniae, by being transported from the alveolar macrophage 
  92 
via the circulating monocyte direct reaches the distant endothelial cell surface25 
(Table 7.2). Indeed, viable micro-organisms facilitate the preferential adhesion of 
infected monocytes to human coronary artery endothelial and smooth muscle cells.  
 




Link between inflammation, infection and atherosclerosis 
 
1. Replication within alveolar macrophages and dissemination within monocytes 
2. Direct infection of coronary artery endothelium 
3. Migrating monocytes carry organism to subendothelial layers 
4. Macrophage activation leading to local inflammation 
5. Cytokine release triggering endothelial damage 
6. Enhanced procoagulant state 
7. T-cell activation 
8. Immune cross reactivity with heat shock proteins 
9. Genetic susceptibility to infection 
 
 
Recently C pneumoniae and Chlamydial heat shock protein (HSP)60 were shown to 
stimulate human vascular muscle cell proliferation and also activate macrophage     
TNF-alpha and matrix metalloproteinases enzymes (which contribute to connective 
tissue degradation and atherosclerotic plaque rupture26). That the Chlamydial HSP60 
and human HSP60 frequently co-localise within atherosclerotic plaques, sheds light 
on an autoimmune process linking infection, inflammation and atherogenesis. In 
contrast to the humoral immunity to C pneumoniae, specific cell-mediated immunity 
in CHD has also been demonstrated. As an additional or independent mechanism               
C pneumoniae may induce a hypercoaguable state promoting atherothrombosis27 and 
enhanced expression of adhesion molecules such, as VCAM and ICAM-1 (as 
discussed by Shah in chapter 4). 
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Antibiotic intervention studies in humans 
Interest in human antibiotic trials in the context of C pneumoniae infection and 
atherosclerosis was triggered by the publication of two pilot clinical studies in 1997. 
In a UK-based study28 survivors of myocardial infarction (MI) were screened for 
antibody levels for C pneumoniae. Increasing anti-chlamydial antibodies were 
associated with increasing adverse cardiovascular events. However, patients with 
elevated IgG antibodies, randomised to receive azithromycin, had a 5-fold reduction 
in events compared to those receiving placebo. Patients receiving azithromycin also 
had a greater change in serum and monocyte markers of activation and inflammation. 
In a similar Argentinean study29, another macrolide, roxithromycin, given to patients 
with an acute coronary syndrome appeared to reduce adverse cardiac events at 30 
days. Inflammatory markers such as CRP decreased more significantly in the                            
roxithromycin-treated group. A series of studies examining the effects of antibiotic 
prescribing and cardiovascular events ensued. Results have been mixed. In a large 
case-control study comparing over 3,000 patients (with an index MI) to over 13,000 
controls the cases of MI were significantly less likely to have been given quinolones 
or tetracyclines (i.e.anti-chlamydial antibiotics) in the preceding 3 years, compared to 
controls30. More recently, Pilote et al showed that exposure to antichlamydial 
antibiotics during the 3 months after acute MI was associated with a small survival 
benefit31. By contract, Luchsinger et al showed that use of such antibiotics in the 
general population failed to confer any benefit in terms of presentation of subsequent 
MI.32. Supporting these findings, the ACADEMIC study (Azithromycin in Coronary 
Artery Disease Elimination of Myocardial Infection with Chlamydia study) showed 
that over a 3 month treatment period, azithromycin failed to prevent adverse 
cardiovascular events at 6 months and at 2 years33, despite reducing certain markers 
of inflammation. The ISAR-3 study randomised patients undergoing coronary 
stenting to receive roxithromycin or placebo34. Although the angiographic restenosis 
rate and mortality rates were no different between the active and placebo groups the 
investigators did identify that those patients with highest levels of antibodies to                      
C pneumoniae and given the antibiotic had a significant reduction in the rate of 
restenosis. Clearly the pathology of restenosis differs to that of atherosclerosis and 
may not necessarily be an aetiological factor in the former scenario. In another 
clinical context the expansion rate of abdominal aortic aneurysms was reduced by 
43% in a roxithromycin-treated group of patients compared to controls35.  
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The anti-chlamydial agents, particularly the macrolides used in these early antibiotic 
intervention studies could be acting through non-antimicrobial effects (e.g.                     
anti-inflammatory actions) thereby halting the progression of atherogenesis 
/atherothrombosis36. Interestingly, other broad-spectrum antibiotics with anti-
chlamydial activities such as tetracyclines inhibit macrophage matrix 
metalloproteinases and hence may hypothetically stabilise the atherosclerotic 
plaque37. Several large-scale trials of anti-chlamydial antibiotic therapy in various 
subsets of patients with CHD are currently underway with some 25,000 patients 
recruited and randomised to receive antibiotic or placebo and under follow up for 
adverse cardiovascular events38. The largest randomised trial (n>7500 subjects), the 
WIZARD Study39 (which includes patients recruited from India) has shown a 7% 
non-significant reduction in major adverse CHD events in post myocardial infarction 
patients given 3 months of azithromycin therapy – although there seemed to be an 
early benefit, particularly in diabetics and smokers. The results of two other large 
trials, ACES and PROVE-IT, will be known in mid-2004.  
 
Infection and atherosclerosis – a current viewpoint 
 
It is plausible that infection, by interacting with the classical risk factors, may 
predispose certain genetically susceptible individuals to atherosclerosis40. Evidence of 
such a modulatory role for C pneumoniae does exist. (C pneumoniae prevalence does 
correlate with hypertension41, cigarette smoking42, hyperlipidaemia43 and male 
gender). The notion that micro-organisms may cause inflammatory or                        
immune-mediated, non-infectious diseases is not new. Helicobacter pylori is now 
recognised as an aetiological factor in peptic ulceration44. Epstein Barr virus has been 
linked to naso-pharyngeal carcinoma45. Mycobacteria have been identified in Crohn’s 
disease46 and Tropheryma whippleii has been linked to Whipple’s disease47. Although 
the focus of this review has been on C pneumoniae the notion of multiple differing 
pathogens and ‘total pathogen burden’ being more contributory to atherosclerosis is 
also plausible48.  
 
Despite the current level of interesting evidence there is no doubt that a number of 
important issues remain unresolved in the ‘infectious hypothesis’. The role of 
antibiotic therapy in CHD also remains controversial49. The diagnosis of                               
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C pneumoniae infection is difficult and there are unclear factors such as re-infection 
rates, optimal length of antibiotic therapies and dosing regimes in addition to the 
potential for resistance to anti-microbial therapy emerging.  
 
Infection, inflammation and atherosclerosis – what relevance for South Asians? 
 
To date, from the Indian subcontinent, investigators have correlated an association 
between markers of chronic C pneumonaie infection and CHD50 (as seen within non-
Asian populations). Furthermore CRP appears to be a stronger pathogenetic factor in 
South Asians than in white Europeans6. Such findings tend to propose that both 
inflammation and infection may have a role in the aetiology and/or progression of 
CHD in South Asian populations too. 
 
Preliminary work from the UK has shown a close association between both previous 
exposure to C pneumoniae and CRP with angina, as defined by the Rose 
questionnaire (although no relationship identified between C. pneumoniae infection 
and CRP)51. Compared with Europeans, subjects of South Asian descent had a greater 
level of serum gammaglobulin (IgG), a non-specific marker of immune activation - a 
disparity that remained even when controlling for cigarette smoking52. 
 
Whether South Asian populations have a greater ‘total infectious burden’ (potentially 
fuelling inflammatory processes) or whether hitherto undefined genetic factors and/or 
altered immune responses (independent of infection) are contributory, merits further 
research. The link between CRP, dyslipidaemia and the metabolic syndrome 
illustrates how the multifactorial nature of CHD needs to be extended in exploring the 
relevance of novel and ‘non-traditional risk’ atherogenic factors for populations such 
as South Asians. Intriguing data also demonstrates that statins and fibrates could exert 
cardio-protective properties by reducing markers of inflammation and endothelial 
activation (in addition to the established lipid-lowering effects) - introducing new 
potential avenues of intervention in those at highest cardiovascular risk and 
intervention at an early pre-clinical stage. 
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Conclusion 
 
We need to remind ourselves of the increasing burden of CHD globally. The 
discovery of ‘new’ risk factors and novel treatments should not be dismissed without 
thorough scrutiny. CHD remains the commonest cause of death in the developed 
world and is projected to continue the trend worldwide. In fact by the year 2020 it is 
projected that in all regions of the world (including former socialist economies, 
emerging economies, countries within the Indian subcontinent and the Middle East) 
cardiovascular diseases will become the leading cause of death1. Most of these 
countries will not be able to have access to or fully afford sophisticated and expensive 
coronary interventions and surgery which the developed world is privileged to. The 
‘infectious hypothesis’ may hence be more relevant in these regions if proven to be 
true.   
 
Clearly the natural history of C pneumoniae infection needs further elucidation as do 
improvements in diagnosis of and monitoring of infection – but this may have to 
follow on or be explored in parallel to clinical trials. Results from large-scale trials 
(and perhaps future trial meta-analyses) may help to clarify the nature of the link 
between C pneumoniae infection and CHD. Perhaps a sub-group of patients might be 
defined to gain the most benefit from chronic antibiotic therapy – rather than 
widespread usage amongst all subjects with CHD.  
 
Although a mere coincidental association between C pneumoniae infection and CHD 
is still a possibility the increasing and diverse lines of evidence and CHD are 
increasing. Definitive proof may only come if subsequent vaccination trials are ever 
felt to be feasible and can be conducted. We eagerly await the results of the next wave 
of antibiotic studies. These may go some way to clarify the nature of the link between 
infection and CHD. Moreover they may help to clarify whether antibiotics have any 
role, if at all, in the secondary prevention of the ‘epidemic’ of CHD. We should 
remain focussed on targeting and treating the established risk factors for CHD using 
the therapeutic strategies of proven and evidence-based value. No doubt, exciting 
research lies ahead to confirm or refute the ‘infectious’ basis to atherosclerosis. 
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8 
 
Nutrition and coronary heart disease in 
South Asians  
 





The diets of the UK South Asian population are diverse, ranging from strict 
vegetarian to meat and fish containing diets. Despite this dietary diversity, central 
obesity and insulin resistance is more prevalent in all South Asian groups when 
compared to the white population.  Total dietary fat intakes are similar to those in the 
white population but the intake of linoleic acid tends to be higher because of the 
widespread use of oils. Vegetarian groups are likely to have low intakes of vitamin 
B12 which can result in elevated plasma homocysteine concentrations. Low dietary 
intakes of vitamin D coupled with low sunlight exposure may also be related to risk 
of CHD. Dietary advice to decrease the intake of saturated fatty acids is prudent but 
advice to decrease total fat intake and increase carbohydrate intake may exacerbate 
insulin resistance. Emerging evidence suggests that advice to consume a diet rich in 
carbohydrates with a low glycaemic index may have favourable effects on insulin 
resistance. There is some evidence that an increased intake of fruit and vegetables, 
nuts and oils rich in linolenic acid may decrease risk of CHD. However, avoiding 
obesity and taking moderate daily physical activity should probably remain the 





As already discussed in earlier chapters, The UK population of approximately 1.6 
million people of South Asian ethnic origin has a higher CHD mortality risk 
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compared to the white population. Young South Asian males account for a substantial 
proportion of this excess. CHD mortality is particularly high in postmenopausal South 
Asian women (see Chapter 1). The dietary habits of the South Asian population are 
relatively diverse and are influenced by religious belief as well as area of origin in the 
Indian sub-continent. According to the 2001 census 1.1% of the total population in 
England stated they were of Hindu faith, a faith which advocates a vegetarian diet. 
Muslims do not eat pork and Sikhs may only eat meat that has been ritually 
slaughtered. Generally South Asian diets are cereal based but the staple food 
consumed depends on the area from which South Asians originate. Wheat is 
predominately grown in the North part of the sub-continent, therefore Punjabis and 
Sikhs consume more wheat. Chicken and lamb/goat are the preferred meats in these 
groups. Bangladeshis are known to prefer rice as it is the main crop cultivated in the 
Ganges delta. Fish is also more popular with Bangladeshis than other South Asian 
groups. Gujaratis consume rice, wheat and also millet.  
 
As discussed earlier, conventional risk factors alone do not explain the excess CHD 
mortality in South Asians (see Chapter 2). It is thought that glucose intolerance and 
hyperinsulinaemia account for much of the excess prevalence of CHD, consistent 
with the hypothesis that metabolic disturbances associated with insulin resistance 
underlie the high risk in South Asians1.  
 
Dietary Patterns  
 
The National Food Survey2 which records household food purchases suggests lower 
total fat intake, higher total polyunsaturated fatty acid intake and a higher 
polyunsaturated: saturated fatty acid intake ratio in South Asians than in whites. 
However, this survey fails to take into account the diverse nature of different South 
Asian diets. Lack of detailed information on ethnicity has meant that the larger 
population surveys have been unable to successfully identify the diets of South Asian 
households. Detailed measurements of dietary intake and an evaluation of dietary 
intake have been made using 7-day weighed food intakes3,4. The proportion of energy 
derived from fat in the South Asian diet is comparable or slightly lower than that in 
the general population5. Vegetable oils such as corn oil are predominantly used for 
cooking and this explains the relatively higher intake of the polyunsaturated fatty 
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acid, linoleic acid. Studies have generally found that dietary intakes are closer to the 
recommended dietary intakes with regard to saturated fatty acids than those of the 
general population particularly in Gujaratis (Table 8.1). Dietary intakes of cholesterol 
are lower and the intake of polyunsaturated fatty acids (PUFA), particularly linoleic 
acid, is much higher in the Gujarati population, who show high levels of 
vegetarianism compared with the general population. However, intakes of saturated 
fatty acids are generally more similar to the general population in Muslims because of 
their intake of fatty meats such as lamb and beef. This is notable in the Bangladeshi 
community in London where the intake of total and saturated fatty acids is relatively 
high5 and is mainly attributable to their preference for lamb and beef, which are fatty 
meats high in saturated fatty acids.  
 
It is important to recognise that dietary habits are changing and the data derived from 
the migrant generation may not necessarily apply to offspring born in the UK who 
have food habits which have become more representative of general population UK 
food habits5,6.  A major limitation to estimating dietary intake in the South Asian 
community has been the lack of reliable food composition data. However, a jointly 
funded project by the Agha Khan Foundation and the Department of Health has now 
published tables of food composition that will help estimate dietary intake in Asian 
diets7.  
 
Table 8.1: Dietary intakes measured in South Asian men and women 
(predominantly of Gujarati origin) as determined by 7-day weighed food intake 
records in North London (Data from Miller et al3 and Reddy & Sanders4) 
 
 Males  Females  
 South Asian White South Asian White 
Energy intake MJ/d 9.3 11.2 6.1 7.5 
Protein (% energy) 12.6 14.3 11.7 15.8 
Fat (% energy) 38.4 38.2 37.3 40.3 
P/S ratio 0.52 0.26 0.66 0.41 
Carbohydrate (% energy) 46.5 43.8 54 43 
Fibre (g/day) 27.8 23.1 16.6 16.2 
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A substantial proportion of the South Asian population who are Hindus follows a 
vegetarian diet and consequently has low intakes of vitamin B12. Combined folate and 
vitamin B12 deficiency resulting in megaloblastic anaemic were more common in the 
South Asian vegetarian population and subsequent studies have shown that elevated 
homocysteine (Hcy) concentrations are more strongly associated with low serum 
vitamin B12 concentrations than with serum folate8. Although, a systematic review 
suggests that elevated plasma Hcy is associated with increased risk of CHD9, the 
difference in Hcy levels between South Asians and whites is not sufficient to explain 
the difference in CHD risk. Furthermore, UK white vegetarians have been found to 
have elevated plasma Hcy concentrations10 due to vitamin B12 deficiency but to have 
a lower risk of CHD compared with the omnivores11. 
 
The type of fatty acid consumed in South Asian diets is quite variable. Vegetarian 
diets tend to contain a high proportion of linoleic acid and are usually devoid of long-
chain n-3 fatty acids. This results in lower levels of n-3 fatty acids in their blood 
lipids3,4. Several large cohort studies have found a relationship between lower intakes 
of long-chain n-3 fatty acids and increased risk of fatal cardiovascular disease and 
randomised controlled trials have found that an increased intake of n-3 fatty acids 
resulted in a significant reduction in fatal CHD12. A study of an Indo-Mediterranean 
diet conducted in India suggested that an increased intake of fruit and vegetables, nuts 
and linolenic acid reported decreased incidence of fatal CHD13. 
 
Research conducted in the Bangladeshi community in East London has revealed a 
strikingly different dietary pattern compared with the predominantly vegetarian 
Gujarati population. In this group intakes of saturated fatty acids tend to be higher and 
the intake of fish is popular14. Boucher15 has suggested that the low intake of vitamin 
D in the Asian population may be related to increased risk of CHD. In the UK there 
was an epidemic of “Asian rickets” in the early 1970’s. The reasons for the decline in 
rickets are complex but in part it may be due to an increased calcium intake and a 
decline in the consumption of phytic acid rich foods. Serum vitamin D 
concentrations, however, still remain low in many Asians16. Boucher’s group15 has 
recently shown that vitamin D supplementation decreases the activity of matrix 
metalloproteinase-9 (MMP-9), which could be of significance with regard to risk of 
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CHD.  MMP-9 is believed to be involved in increasing susceptibility to plaque 
rupture (as discussed by Shah and Kearney in chapter 4). 
 
Diet and insulin resistance 
 
Measurements of fat patterning have been able to discriminate differences between 
children of South Asian origin compared with whites and it is possible to detect early 
signs of insulin resistance in South Asian children. Pioneering studies carried out by 
Miller17 in the Caribbean showed that men of South Asian origin had lower 
concentrations of HDL cholesterol and higher plasma insulin concentrations 
compared with other ethnic groups and that this was associated with increased risk of 
CHD. These findings have been replicated in other communities originating from the 
subcontinent of Asia, for example in Singapore and South Africa. General dietary 
advice that emphasises a substantial reduction in total fat intake and a large increase 
in carbohydrate intake may be less appropriate for the Asian population. Indeed such 
dietary interventions have been found to result in an increase in plasma triglyceride 
concentration and a reduction of in HDL cholesterol concentration which is consistent 
with increased insulin resistance18.  
 
Life-style interventions to reduce risk of CHD in South Asians 
 
The key issue with regard to the prevention of CHD in the South Asian community is 
probably to modify lifestyle factors that decrease the consequences associated with 
insulin resistance. There is convincing evidence19 that moderate physical activity and 
a decrease in body weight improve insulin sensitivity and features of insulin 
resistance. However the role of dietary fat composition is less certain. Diets high in 
saturated fatty acids probably exacerbate insulin resistance20 and given their plasma 
cholesterol raising effect, there is consensus on the need to decrease population 
intakes of saturated fatty acids. However, an issue of dietary carbohydrate quality and 
specifically, the glycaemic index of carbohydrate21, may be of particular importance.  
Indeed, there is some evidence of an improvement in insulin sensitivity in South 
Asian subjects advised to follow a diet with a low glycaemic index22. The glycaemic 
index can be lowered by replacing starchy foods such as ordinary rice and chapattis 
with versions that have a lower glycaemic index and by decreasing the intake of 
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sugary foods. Interestingly the glycaemic index of a food such as rice is dependent on 
its source and how it is processed. Wholegrain cereals usually have a lower glycaemic 
index than refined cereals (except for bread).  Basmati rice and parboiled rice have a 
substantially lower glycaemic index compared with ordinary boiled rice.  The pattern 
in which food is consumed also has an impact on insulin sensitivity – with smaller 
doses spread throughout the day having a more favourable effect than the 
consumption of a large amount in a single meal. Consequently, in order to modify the 
overall glycaemic index of a diet requires altering both the pattern of carbohydrate 




The Department of Health COMA panel23 made several recommendations for the 
prevention of CHD in the UK. However, these did not specifically cover the needs of 
the South Asian population, for whom translation of this advice needs to be refined. 
There is also a need to develop a sounder scientific basis for dietary advice for the 
prevention of CHD in the South Asian population. The current knowledge suggests 
that it is prudent to restrict the intakes of saturated fatty acids and to encourage an 
increased intake of fruit and vegetables and oils rich in linolenic acid. There is 
promising research that suggests that decreasing the glycaemic index of the diet may 
be of value in preventing/managing insulin resistance but further research in this area 
is needed.  These aspects of diet coupled with regular physical activity, avoidance of 
obesity and decreasing the intake of saturated fatty acids are currently the most 
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9 
 
Hypertension and coronary heart 
disease in South Asians  
 




Coronary heart disease and stroke are dominant causes of death in South Asian 
populations in the UK and the rates are even higher than in the white population1. As 
a major cardiovascular risk factor, hypertension needs to be carefully managed in 
South Asian populations. There is a perception that in South Asians blood pressures 
are comparatively high. Studies in the UK on comparisons between South Asian and 
white populations in blood pressure and prevalence of hypertension have, however, 
given inconsistent conclusions. This chapter discusses blood pressure and prevalence 
of hypertension data on samples of South Asian populations in the community in 
comparison with a white or general population in the UK. 
 
Blood pressure levels 
 
The common perception that blood pressure in South Asians is comparatively high is 
unreliable – the picture is more complex than this. Overall, blood pressures are 
similar but there is stark heterogeneity in South Asian adults with similar or slightly 
higher blood pressures in Indians, slightly lower blood pressures in Pakistanis and 
much lower blood pressures in Bangladeshis. The available data on blood pressure 
and prevalence of hypertension in the UK show that most studies reported lower 
mean systolic but higher diastolic blood pressures in South Asians in both males and 
females compared to whites2. For example, of the 13 community based studies (Table 
9.1) in the UK analysed3-15, 8 reported lower mean systolic blood 
pressure3,4,8,9,11,12,14,15 and 7 reported higher mean diastolic blood pressure3,5,7,9,10,12,13 
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in South Asian males compared to white males.  Of the 9 studies on females,6,7,9-14, 6 
reported a lower mean systolic blood pressure4,6,9,11-13 and  5 reported a higher 
diastolic blood pressure7,9,10,12,13 in South Asians compared to whites.  
 
Table 9.1. Blood pressure levels (mean) and prevalence (%) by ethnic group (this 













SBP             DBP             % PH  
FEMALES 
 





134.2*         78.7               22%           




London Non-Asians  
Bangladeshis 
129***        81              Not given 
119              78                   
123*          78           Not given 





138.0           86.1               21% 






129              77                  20% 
137              77                  32%                  
128             75           34% 
123             66          13% 




121              78               Not given 
126              82                 
120             76        Not given 
126             77 
Knight  
(1992)8 
Bradford Non-Asians  
Asians 
137.4 **      79.6               23.1% 




Glasgow Gen. Population  
South Asians 
124.5           80.3               14%        
123.8           86.3**           22% 
115.3          74.0        5% 






                                        WHO     JNC   
127.9           82.1               28%     18%    
131.0**       85.4***         44%     33%   
                                  WHO   JNC   
 123.5         77.2         24%    13%    












129.1***     78.1**           18% 
119.2           70.6               10%  
 
123.9           72.1               14% 
119.0           70.9                9%  
112.1           67.5                6% 
121.2***    68.8         12% 
117.7          67.9         14% 
 
122.6          68.4         15% 
115.7          68.0         12% 





123.4**       76.8               OR 1 
121.4           77.4               OR 2.3 
           males & females mixed 
120.0          75.0 





40 and above 
South Asians 
16-39 
40 and above 
 
132.2**       70.3                 4% 
141.6           81.5                36% 
 
129.5            71.9                3% 
143.5            84.1***         51%*** 
 
122.8**      68.1          2% 
138.0          75.8         35%  
 
118.9          67.2          2% 








           SRM           SRM                 SRR 
136.8   1       76.2   1          40.8%   1   
134.0   1.0    77.7   1.03     35.7%   1.03 
129.7   0.98  72.5   0.99     25.5%   0.89  
126.5   0.94  72.9   0.99     23.6%   0.74 
          SRM                             SRR 
132.5   1                     32.9%   1 
126.2   0.99                23.6%   1.12 
122.9   1.02                16.1%   1.25  
120.2   0.97                12.3%   0.89 





129.5            80.4               19.4% 





SBP = Systolic Blood Pressure, DBP = Diastolic Blood Pressure, BP = Blood Pressure, OR = Odds 
ratio, SRM = Standardized Ratios of Means, SRR = Standardized Risk Ratio, % PH = Prevalence of 
Hypertension, (WHO) criteria = BP≥160/95 mm Hg or on drug therapy,  (JNC) criteria = BP≥140/90 
or on drug therapy,  *p<0.05, ** p<0.01, *** p<0.001, comparing ethnic groups 
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Prevalence of hypertension 
 
Whilst more studies have reported higher prevalence rates of hypertension in South 
Asian males compared to white males, the prevalence rates in South Asian and white 
females have shown inconclusive results. For example, of the 11 studies on the 
prevalence of hypertension using various cut-off points3,5,6,8-15, 5 reported 
higher5,6,8,9,10 and 3 studies reported lower3,11,15 prevalence rates in South Asian males 
compared to white males. In Primatesta et al, the prevalence rate was lower in the 16-
39 year group but higher in the 40 and above year group compared to whites13. In 
Karlsen et al’s study, the observed prevalence of hypertension was lower in South 
Asian groups than in whites. However, after adjusting for the effects of age and 
presenting data in the form of relative risk ratios (comparing each sub-group to the 
overall general population), the age standardised risk ratios were lower in 
Bangladeshi and Pakistani males but higher in Indian males than in white males14. Of 
6 studies reporting on females6,9-11,13,14, 2 showed higher prevalence rates10,11, 1 
showed the same rates9 and 2 showed lower rates6,13 in South Asians compared with 
whites. Bhopal et al11 found the prevalence in Bangladeshi females to be much lower 
than in Europeans. In Karlsen et al’s study the observed prevalence rates were lower 
in South Asian groups. However, after the effect of age has been controlled for, the 
age standardised risk ratios were higher in Pakistani and Indian females but lower in 
Bangladeshi females compared to white females14. Whitty et al’s study result was 
based on males and females combined and reported higher rates in South Asians than 
in whites12.  
 
Both mean blood pressure and the prevalence of hypertension data show important 
differences between South Asian subgroups11,14 yet most studies combined them as 
one homogenous group. Data also show regional variation between the London area 
(higher BP) and the rest of the UK (lower BP). While lower blood pressure in 
Bangladeshis was associated with a lower BMI, differences in obesity clearly did not 
account for much of the ethnic variation2. In three studies16-18 based on clinically 
selected patients, hence excluded by Agyemang and Bhopal’s systematic review2, 
blood pressure levels were lower in South Asian populations than in the white 
population. 
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The problems of comparison in UK studies 
 
Results of the UK studies are not clear-cut. Inconsistent results could be explained by 
differential representation in sample populations by Indians, Pakistanis and 
Bangladeshis and variations in the methodology of different studies. These factors 
make inter-study comparisons unreliable and hence intra-study variations between 
ethnic subgroups are more important. The importance of heterogeneity among South 
Asian groups has long been emphasised but generally neglected19. Variations in South 
Asian subgroups are especially important in the context of cardiovascular diseases, 
where risk factor profiles and disease outcomes differ too11,20. Heterogeneity among 
the UK ethnic groups study populations may be a general explanation for inconsistent 
results from prevalence of hypertension studies.  
 
Huge variations in methods of measurement of blood pressure limit the capacity to 
synthesise UK data. For example, in some studies, participants’ blood pressures were 
measured with a Hawksley random zero sphygmomanometer3-7,9. In other studies13,14 
a Dinamap 8100 monitor was used which tends to provide higher systolic and lower 
diastolic blood pressure levels than mercury sphygmomanometer readings21,22. 
Participants’ blood pressures were measured in different locations and the cut-off 
point used for diagnosis of hypertension varied too. The estimated effect of whitecoat 
hypertension ranges from 12 to 53 % depending upon the population studied and 
definition used23,24. It is difficult to account for the effect of whitecoat hypertension in 
each study. It is also not clear whether the effect of whitecoat hypertension differs in 
different ethnic groups25. The UK studies span approximately 20 years, which 
potentially affects the comparability and interpretability of results. Middle-aged South 
Asians at the end of the 20th century were also likely to be different from their 
counterparts in the early 1980’s, with respect to immigration, behaviour and socio-
economic status. Differences in BMI, age and sex further complicate the findings of 
the UK studies. 
 
Some studies5,6,7 used country of birth as an indicator of ethnicity. This implies that 
many Indians, Pakistanis and Bangladeshis who were born in the UK were excluded.  
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Heterogeneity by ethnic subgroup and region 
 
The Newcastle Health Project study and the Health Survey for England ’99 are the 
two studies that paid particular attention to the heterogeneity of the South Asian 
populations in the UK11,14. The Newcastle study found major differences among 
South Asian subgroups. Bangladeshi males and females had lower mean systolic and 
diastolic blood pressures than Indians and Pakistanis. Prevalence of hypertension was 
less common in Bangladeshis in both males and females than in Indian and Pakistani 
groups11. In the recent Health Survey for England ’99 similar findings emerged. 
Bangladeshi males and females had lower age-standardised mean systolic and 
diastolic blood pressure and a lower prevalence of hypertension than their Indian and 
Pakistani counterparts14. These two studies emphasise the importance of studying 
South Asian subgroups separately rather than combining them as one homogeneous 
group, which may make other studies misleading. For example, McKeigue et al’s 7 
study classified South Asian subgroups on the basis of language and religion. This 
study found significantly higher systolic blood pressure in Sikh (128 mm Hg n=731) 
and Punjabi Hindus (128 mm Hg n=159) than in Muslims (120 mm Hg n=211) and 
Gujarati Hindus (122 mm Hg n=127). Despite these differences they were combined 
as one group. 
 
The UK data also show a regional variation between the London area (comparatively 
high blood pressure in South Asian males) and the rest of the UK (comparatively 
lower or similar blood pressure). Most studies in London show higher mean systolic5-
7,10 and diastolic5,7,10,12  blood pressures in South Asian males than in white males. By 
contrast, all studies3,8,9,11,15 in cities outside London show lower mean systolic blood 
pressure in South Asian males compared to white males. Prevalence data also show 
similar patterns in South Asian males. Higher blood pressure levels reported in the 
London area as opposed to other cities outside London may reflect different 
environmental risk factors experienced by ethnic groups living in different parts of 
the UK or perhaps more likely, a different population mix. It is possible that London 
studies which reported higher blood pressure levels in South Asians might have 
consisted mainly of Indians. For example, Cruickshank et al’s 6 and McKeigue et al’s 
7 studies reported higher blood pressure levels in South Asian groups. McKeigue et 
al’s study drew a large part of the South Asian sample from 16 general-practices in 
  114 
the London borough of Ealing. This borough is composed of 16.1% of Indians (many 
of them Sikh Punjabis)26. Also, in Cruickshank et al’s 6 study, the South Asian 
subjects were mainly Gujarati Indians. In contrast, in McKeigue et al’s 7 study in the 
London borough of Tower Hamlets with a predominantly Bangladeshi population26 
blood pressure levels were lower compared to whites.  
 
The studies that have a representative sample of the adult population show lower or 
similar blood pressure levels in South Asian males compared to white males3,8,11,13,14. 
By contrast, most studies on older adults show higher blood pressures5,6,7,10,13 and 
higher prevalence rates5,6,10,13 in South Asian males than in whites. Primatesta et al’s 
study had a representative sample of both younger and older adult populations12. The 
older South Asian males group had a higher blood pressure and a higher prevalence 
rate but the younger South Asian males group had a lower mean systolic blood 
pressure and lower prevalence rate than white males12. It may be that the younger 
generation of South Asian groups have different blood pressure patterns than the 
previous generation. Our preliminary observations on South Asian children indicate 
that the heterogeneity has diminished with Bangladeshi children not enjoying the 
comparatively low blood pressure their parents have27. 
 
Blood pressure, prevalence of hypertension and pulse pressure 
 
A higher prevalence of hypertension was not always associated with higher blood 
pressure in that population. For example, Miller et al’s study reported a marked 
excess of hypertension in Indian males but average blood pressure levels were similar 
in all ethnic groups5. Again, in Knight et al’s study, the prevalence of hypertension 
was higher in South Asian than non-South Asian males but systolic blood pressure 
was higher in non-Asians8. The possible explanation for this is that either the 
percentage on antihypertensive treatment differs or the distribution of blood pressure 
is skewed. In Miller et al’s study a larger number of Indians were on antihypertensive 
therapy compared to whites (p<0.05)5.  
 
A lower mean systolic blood pressure but a higher mean diastolic blood pressure 
reported in South Asians in both males and females implies lower pulse pressure. 
Evidence on pulse pressure as a marker of cardiovascular risk is well established 
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especially for CHD28,29. This finding of lower pulse pressure in this review is in direct 
contrast with the evidence of higher coronary events in South Asian populations 
particularly in Bangladeshis20. 
 
Blood pressure and disease outcomes 
 
A meta-analysis of nine major prospective studies has shown an important association 
between increased blood pressure and stroke and CHD30. There are some problems in 
extrapolating these data to all ethnic groups, as it is unknown whether the 
physiological optimal level of blood pressure is the same in each group31. For 
example, it remains uncertain whether for a given level of blood pressure South Asian 
populations will have a higher risk of death than white people. Findings from the St 
James Study in Trinidad showed that the attributable mortality (the sum of the 
products of attributable risk and age-adjusted prevalence in each pressure group) after 
8 years (in deaths/1000 person years) from a systolic blood pressure between 155 and 
179 mm Hg was 12.3 for Indian and 8.2 for European males, and above 180 mm Hg, 
22.8 and 15.1 respectively32. Bangladeshis have a lower mean systolic and diastolic 
blood pressure than Indians and Pakistanis11,14, but a higher mortality from stroke 
than their Indian and Pakistani counterparts20. These differences may be a result of an 
interaction between risk factors. Among South Asian sub-groups it may be that for a 
given level of blood pressure the Bangladeshis will have higher risk of death than 
Indians or Pakistanis. These findings seem to suggest that the reporting of blood 




Blood pressure levels and prevalence of hypertension differ across groups. Some of 
the inconsistent results in the UK studies could be explained by the variations in 
methods of measurement of blood pressure and classifications of South Asian groups. 
Differences in age, sex and BMI also potentially confound findings. A growing 
proportion of people from India, Pakistan and Bangladesh origin are UK born. There 
is, therefore, a strong case for epidemiological research among younger groups to 
examine blood pressure levels and prevalence of hypertension and how this pattern 
may be changing. The early observations are a warning27. Future research must 
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recognise the various subgroups of South Asians and should be designed in such a 
way that data can be combined easily, for example by standardising the way in which 
blood pressure is measured. Given the observations on blood pressure levels and the 
risks of stroke and CHD, clinicians need to tackle hypertension, and its causes, with 
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Smoking and smoking cessation in 






Tobacco smoking is a well established risk factor for CHD. In subgroups of the South 
Asian populations, the prevalence of smoking habits varies significantly. South Asian 
females rarely smoke in these populations (or at least rarely report smoking, though 
this is changing in the younger South Asians), whereas the prevalence of smoking in 
males varies according to ethnic subgroup (Table 10.1) e.g. in the Health Survey for 
England ’991, 44% of Bangladeshi males smoked compared to 23% of Indian males, 
the former higher and the latter lower than the prevalence of smoking in the general 
population. Within South Asian communities, there is a link between the observed 
rates of smoking and socio-economic deprivation. Higher rates of smoking in certain 
groups can also be attributed to the ‘social acceptance’ of smoking2. It has been 
argued that the heterogeneity of South Asian populations is an important 
consideration in developing health programmes3.  Many health professionals regard 
South Asians as one community. However there are many differences between 
individual groups in terms of religion, customs, traditions, languages, education, and 
economic status. Their attitudes and beliefs about health and disease also differ. 
Therefore, in designing smoking cessation programmes for South Asians this 
heterogeneity should be taken into account. In addition, the ‘chewing’ of tobacco and 
related products is common in certain South Asian communities, particularly the 
Bangladeshi community, in both males and females.  
 
This chapter will focus on smoking cessation behaviour in South Asian communities, 
examining the impact of national initiatives on smoking prevalence in these 
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communities. The chapter will also highlight the reasons why these communities need 
specific targeting and innovative approaches to reduce smoking.  
 
Table 10.1 Smoking and quitting rates for South Asian groups compared to the 
general population. Extracted from the Health Survey for England 19991 
 
 Males Females 





Indian 23% 2% 61% 35% 6% 6% 
Pakistani 26% 2% 55% 21% 5% 6% 
Bangladeshi 44% 19% 71% 19% 1% 26% 
General 
Population 
27% NS >70% 54% 27% NS 
 




Following the 1998 White Paper on smoking4 the government has undertaken several 
national initiatives. The major achievements as result of this paper have been the 
establishment of specialist smoking cessation services in every primary care trust and 
the availability of nicotine replacement therapy (NRT) and bupropion (Zyban) on 
prescription to those patients deemed ready for smoking cessation. 
 
Quitting smoking amongst South Asians 
 
Table 10.1 shows that in terms of attempts at quitting, the intention of South Asian 
male smokers to give up is similar to the general population. However, actual quit 
rates are much lower than in the general, predominantly white population, and the 
utilisation of services designed to help people give up smoking is lower in South 
Asian populations. Most smoking cessation services have failed to attract ethnic 
minority groups. However services designed specifically for ethnic groups such as 
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those in Coventry, Bradford, Camden and East London, have attracted fairly large 
numbers of Asian smokers. This suggests that service adaptations are necessary for 
addressing the needs of South Asian smokers. The justification for programmes 
specifically targeted to particular groups takes into account the higher prevalence of 
smoking of Bangladeshis and the fact that there are language and cultural barriers 
inhibiting smokers from many ethnic minority groups from joining specialist clinics. 
 
Reasons why quitting rates are lower amongst South Asians 
 
To see how we should address the problem of lower quit rates amongst South Asian 
groups, one needs to identify the reasons for this phenomenon. Bush et al2 pointed out 
that the social acceptability of smoking in Pakistani and Bangladeshi communities 
might contribute to a lower quit rate. In our experience at the BHF we have found the 
following reasons for lower quit rates 
•  A low level of awareness amongst South Asians of the health risks associated 
with smoking. 
• Low awareness of the addictiveness of cigarettes. 
• Very little awareness of the availability of NRT and bupropion, and of their 
effectiveness.  
• A social acceptability of smoking in some Asian groups. 
• Fatalistic attitudes to health. 
• Perception of a lack of control over health. 
• Low self esteem. 
• Poor socio-economic conditions. 
 
According to the, ‘Black and Minority Ethnic Groups in England, the second lifestyle 
survey (2000)’, South Asians’ knowledge of the health risks of smoking is poor5. 
Only 25% of South Asians perceive there to be a link between cigarette smoking and 
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The British Heart Foundation strategy 
 
Where attempts are made to quit smoking, outcomes are not as successful as for the 
general population (data drawn from HEA 2000). Consequently a three-step approach 
to reduce the prevalence of smoking is advocated by the British Heart Foundation 
(BHF). The first step is to bridge the knowledge gap. The BHF recommend the use of 
the media, places of worship and social networks. The second step is to ensure that 
the community feels empowered to make positive lifestyle changes and for this, 
community involvement and a developmental approach is required. An ‘attitude and 
norm change’ strategy would assist in reducing smoking. Campaigns to reduce 
exposure to second hand smoking at home and the workplace would also help. 
Thirdly, the variety of methods available to quit smoking need to be widely applied. 
The BHF policy calls for actions to facilitate this three-step approach, in particular 
ensuring that the knowledge gap is addressed and available services are promoted.  
 
Bridging the knowledge gap 
 
In 2002 just prior to the national ‘No Smoking Day’ the BHF conducted a small 
survey of knowledge about NRT and bupropion at Asian Quitline and found that only 
3 callers out of a poll of 100 knew about Zyban and only 6 had heard about NRT. 
Most callers were unaware that these aids could potentially double their chances of 
quitting. Unless this gap in knowledge and awareness about smoking cessation aids is 
addressed it is unlikely that one will witness an increase the number of quitters from 
South Asian communities. It is noteworthy that many Asians in deprived inner city 
areas are registered with ‘single handed practices’, where general practitioners may 
not have time to give detailed advice about smoking cessation. Asian Quitline has 
also noted that where patients have had cardiac surgery or myocardial infarction, they 
are rarely informed about NRT or bupropion. GPs surgeries can, however, be used by 
advisors to give information on quitting. It has been found that opportunistic health 
education, provided to members of ethnic minorities, at the time of clinic attendance, 
has been well received by both sexes6.   
 
To bridge this knowledge gap Asian media can play a central role. At Asian Quitline 
the number of calls are significantly increased when media campaigns using popular 
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South Asian media are undertaken. There is also anecdotal evidence that first 
generation South Asians prefer such media and tend to watch South Asian TV 
channels more than mainstream channels.  
 
To overcome the difficulties of reaching minority ethnic groups many health 
promoters have started to train community workers in health issues in the hope that 
they may pass on information to others. There are examples of health promotion 
services running courses for community workers covering diverse health issues (e.g. 
Project Dil 2002 in Leicester). Furthermore many primary care trusts have trained 
smoking advisors who are working with ethnic minority groups (Camden PCT 2002). 
Smoking guidelines7 have suggested and reinforced this practice of the use of paid 
trained community workers.  
 
To increase the awareness of dangers of smoking and available methods of quitting, 
places of worship can also play a major role. On important religious festivals, large 
mosques, gurudwaras and mandirs can attract thousands of people and with the help 
of these institutions health promoters can reach significant numbers within these 
communities.  
 
The BHF have been funding Asian Quitline since 1997 to provide culturally 
appropriate telephone counselling and support service to those smokers who wish to 
quit smoking. Asian Quitline has also been involved in outreach work, in which it has 
been working with community groups, places of worship and has been involved in 
training of health professionals to equip them to deliver culturally sensitive smoking 
cessation programmes in the community. For the past five years Asian Quitline have 
been running a Ramadan campaign. In this campaign mosques in the UK are targeted 
using Imams who have been trained in giving basic smoking cessation advice. 
Furthermore, trained lay smoking advisors are also used to provide one-to-one 




Providing information is not sufficient. Although understanding a health issue may be 
a necessary precursor to action, it is certainly not sufficient. It should be accompanied 
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by a process of belief and values-clarification which should be followed by some 
practice in decision making and this would increase the capacity to freely choose 
from various alternatives. Bhopal & White8 have argued that skills and confidence to 
change behaviour are more important than knowledge. This process increases the 
self-esteem of participants, particularly those with low self-esteem, who are unlikely 
to look after themselves. It has been mentioned that contrary to popular opinion older 
South Asians feel lonely and isolated which may lead to low self-esteem9. This may 
also reduce the probability of quitting smoking. Therefore individual and community 
empowerment would lead to higher smoking cessation rates.  
 
Bush et al2 have found that smoking among Pakistani and Bangladeshi men is seen as 
socially acceptable and, not surprisingly we see higher levels of smoking among 
them. In contrast smoking in women in these groups is stigmatised and not 
acceptable, hence there is a low rate of smoking among women. Therefore, one must 
work to change prevailing norms and attitudes within minority ethnic societies. This 
can only be achieved by working with social, community and religious leaders. 
Hopefully, this may create an environment where smoking is generally viewed as 
being ‘socially unacceptable’. ‘Denormalisation’ is based on the notion of changing 
social norms. The social norm change model is based on the fact that the thoughts, 
values and actions of individuals are tempered by their community10  
 
Within the individual household setting one will also need to raise awareness of the 
harmful effects of second-hand tobacco smoke. Here one may work with young 
people and have them encourage parents, relatives and visitors not to smoke at home. 
 
Relative merits of methods for quitting smoking 
 
According to the Government White Paper on Tobacco (1998), ‘a full course of 
specialist counselling combined with NRT can lead up to 25% of smokers to give 
up’4. There is strong evidence of the effectiveness of NRT (in the form of chewing 
gum, transdermal patch, nasal spray, inhaler, tablet or lozenge) in assisting smoking 
cessation for nicotine dependant smokers. This intervention increased the chances of 
smoking cessation by one and a half to two times7. However, all trials combined NRT 
with at least brief advice, and the quit rate was higher when NRT was combined with 
  126 
intensive support. There is, therefore, a strong argument for the use of brief advice to 
be offered as a minimum in support of NRT (National Electronic Library for health 
and heart disease website: ‘Which interventions are most effective’ and National 
Institute for Clinical Excellence11). According to the National Service Framework 
(NSF) for coronary heart disease12, studies from the United States of America suggest 
that smoking cessation interventions with black and minority ethnic groups can be 
effective. The NSF (2000) also states: 
• Literature should be multi-lingual and in a culturally appropriate style. 
• Communications campaigns should be used to redress misperceptions about 
tobacco use. 
• Ethnic differences in terms of attitudes and beliefs towards tobacco should be 




Smoking prevalence in the most economically deprived South Asian communities is 
higher than in the general population, but desire to quit in these communities is 
similar to that in the general population. However due to cultural acceptance of 
smoking and lack of awareness of smoking cessation aids, language and cultural 
barriers, cessation rates are lower than general population. To decrease smoking 
prevalence and encourage smokers to quit we need a comprehensive strategy which 
South Asian media, social and religious leaders and social networks could use to 
change norms to make smoking socially unacceptable. Help and support tailored to 
their need, should be provided to those who wish to quit. A grass roots approach is 
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Physical inactivity is an established independent risk factor for CHD, diabetes, stroke, 
hypertension, obesity and osteoporosis1. It is also thought to be important in 
promoting mental health2. Physical activity has direct, positive effects on 
cardiovascular and respiratory systems, and on glucose and lipid metabolism. 
However, these positive effects are short-lived and lost once regular activity ceases. 
In other words, only regular physical activity is truly beneficial.1 
 
A detailed understanding of the experience of physical activity among South Asian 
communities is essential to underpin the development of effective interventions to 
promote regular exercise. This paper sets out to answer a number of questions 
pertinent to this challenge: 






Are there generational differences?   
How good is their knowledge of the benefits of regular activity?   
What are their attitudes to physical activity?   
Are their reasons for inactivity specific to South Asian communities?   
What can be done to promote physical activity in South Asian communities 
 
In reviewing physical activity among South Asians, I have drawn on the work of a 
limited number of authors. Although these do represent the main work on this topic, it 
is important to stress that this is not a systematic review.  Our work on the 
epidemiology of cardiovascular diseases and diabetes among South Asians has 
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demonstrated the importance of studying distinct ethnic sub-groups within the South 
Asian population3. Thus a key criterion for choosing studies was their ability to 
distinguish between Indians, Pakistanis and Bangladeshis.  The studies I have 
reviewed are as follows: 
1. The Health Survey for England ’994. This biennial national survey used questions 
originally derived from the Allied Dunbar National Fitness Survey5 and, in 1999, 
had a particular focus on ethnic minority groups, with a sample boosted to 
represent the main ethnic groups in England.  It provides descriptive 
epidemiological data on level and intensity of activity, but little explanatory 
analysis and no qualitative data. 
2. The Health Education Authority (HEA) 2nd health and lifestyles survey of black 
and ethnic minority groups in England, 19946. This representative population 
survey focused on ethnic minority groups and, as well as collecting data on levels 
of activity, asked about types of activity, opportunities and barriers to activity, and 
knowledge and attitudes. 
3. The National Study of Health & Growth7. This is the only study of health related 
behaviours among children that reports data specifically on ethnic minority 
groups. However, South Asians are not distinguished by ethnic sub-group. 
4. The Newcastle Heart Project, 1995-73, 8, 9. Although a local epidemiological 
study, this study has a geographically representative population coverage and 
detailed data on both health behaviours and health states, including cardiovascular 
disease. 
 
How inactive are South Asian males and females?   
 
In the Health Survey for England4, there was an ethnic gradient in participation in 
sports and recreational exercise among adults, with highest levels in the general, 
predominantly white population, followed by Indians, then Pakistanis, with the lowest 
levels in Bangladeshi males and females. Males were more likely to engage in regular 
sports and heavy manual or ‘DIY’ activities than females. Significantly fewer males, 
however, undertook regular, heavy housework, and this pattern was the same in all 
ethnic groups. There was also an ethnic gradient in brisk walking in both males and 
females, with highest levels in the general population and lowest in Bangladeshis 
(Figure 11.1).  
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Figure 11.1: Participation in physical activity in previous 4 weeks by ethnic 
 
group4 
 the Newcastle Heart Project, there were similar ethnic gradients for achievement of 





























national physical activity targets (at least 30 minutes of at least moderate activity on 5 
days of the week10) among adults aged 25-74 years, with European origin study 
participants most active and Bangladeshis least active and, apart from among 
Pakistanis, males being more active than females.  However, even among European 
males (the most active group), only 48% were achieving this target level; among 
Bangladeshi females (the least active group), only 9% achieved this target. With 
regard to vigorous activity, only 1% of Bangladeshi females are regularly active, 
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Are there generational differences?   
 
In the national data, there was a strong age gradient, with lowest levels of activity in 
ose aged over 55 years in all ethnic groups, suggesting there is no ethnic group 
ns adults in Britain are generally less active than Europeans, 
oth in terms of participation in sports and in ‘lifestyle’ activity. Among South 
nefits of regular activity within South Asian 
ommunities?   
ack and Minority Ethnic Groups survey, South Asian adults were 
sked: “What serious illness or health problems are linked to not taking enough 
th
specific generational effect4. However, perhaps more worrying, in their National 
Study of Health & Growth, Bettiol et al showed that, in comparison with White and 
Afro-Caribbean 8-9 year olds, three times as many children of families from the 
Indian sub-continent (India, Pakistan and Bangladesh) were unable to complete a 
cycle ergometer test (to 85% of maximum heart rate) for physical fitness7. Whilst the 
authors acknowledge that there may be some bias, resulting from unfamiliarity with a 
bicycle among the Asian children, it is unlikely to have accounted for such a large 
difference in fitness.     
 
In summary, South Asia
b
Asians, Bangladeshis are least active and Indians most active. Studies of children 
show South Asians to be less active and less fit than European children. To explore 
further the possible reasons for these findings, I have looked at data on attitudes to, 
and knowledge of, physical activity. 
 




In the HEA’s Bl
a
exercise?”.  The most commonly mentioned problems were ‘being overweight’ (41% 
overall, with little ethnic difference), ‘heart disease’ (32% of Indian and Pakistanis, 
17% of Bangladeshis); ‘joint problems’ (11% overall, with little ethnic difference); 
and ‘diabetes’ and ‘stroke’ (6% overall, with little ethnic variation).  Perhaps more 
worrying was the fact that around 20% of Indian males and females and Pakistani 
females did not know of any related health problems, whereas 26% of Bangladeshi 
males, 29% of Pakistani females and 38% of Bangladeshi females knew of no health 
problems associated with lack of activity6. Given the rapid current growth of chronic 
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diseases among South Asian ethnic groups, especially Bangladeshis and Pakistanis3, 
this is a worrying deficit in important risk-related knowledge. 
 
In summary, knowledge of physical activity reflect gradients in activity: Bangladeshis 
ppear least knowledgeable compared with Pakistanis and Indians. 
ng South Asian 
ommunities?   
ck and Minority Ethnic Groups survey explored attitudes and 
nowledge of physical activity. Pakistani and Bangladeshi females, who have the 
en’ (29%) 
nsufficient time’ (26%); 
eople show parts of their bodies’ (19%); 
herwise rarely mentioned and it is important to 
mphasise that 40% of females and 70% of males said none of the listed ‘ethnic group 
ysical activity are more 
revalent among Pakistanis and Bangladeshis, especially females, but overall, these 
r reasons for inactivity, specific to South Asian communities?   
UK 
 their relative economic position. This has been explored in relation to 
cardiovascular disease9 as well as other health states11, and it is widely recognised 
a
 





lowest levels of activity, reported the key reasons6 for non-participation in 
recreational activities as:  
 
‘looking after young childr
‘i
‘won’t go to mixed-sex facilities’ (20%); 
‘won’t go to places where p
‘fear of going out alone’ (17%). 
 
Language and culture were ot
e
specific’ reasons for inactivity applied to them. 
 
Ethnically specific factors affecting participation in ph
p





One important factor relating to the social context of South Asian families in the 
is
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that a socio-economic gradient exists, with Bangladeshis having the lowest incomes 
and social status in the UK, followed by Pakistanis, with Indians enjoying a socio-
economic status almost equivalent to the general population11. The relationship 
between social class, ethnicity and participation in activity was explored in the 
National Health Survey for England (Figure 11.2).   The pattern is somewhat curious.  
 
Figure 11.2: Participation in vigorous activity for 30 minutes on 5 or more 
days/week, by social class, ethnicity and sex  
 




















Although the ethnic trends are as expected for males and females from manual social 
classes, and for females from non-manual social classes, the trend is reversed for 
m
and managers are more likely to take regular vigorous activity than those from other 
ethnic groups. Thus we can see that among the general population and Indians, males 
in manual social classes were more likely to be vigorously active than males in non-
manual social classes. The same effect was seen for females among the general 
population. These patterns may, in part, be related to different patterns of occupations 
among the different groups, and thus seen as part of a more general pattern of socio-
economic transition among these ethnic minority populations. Occupations, income 
and social status are known to play important roles in determining levels of physical 
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activity in the general population and may also have specific effects among South 
Asian communities. 
 
What can be done to promote physical activity in South Asian communities? 
ote 
hysical activity among South Asian communities8, 12. The evidence base to support 
ow enough about the reasons why South Asians are so inactive, nor 
hat would help to promote greater activity. Greater understanding requires further 
ted to our research on South Asians in Newcastle and they are 
cknowledged in Reference 3 below. Raj Bhopal and Louise Hayes in particular 
provided helpful advice and support on work discussed in this paper. 
 
There is little evidence to support the implementation of interventions to prom
p
interventions in the general population is also weak and few interventions have been 
shown to have long-term effectiveness13.  Some interventions have been tested among 
South Asian groups (e.g. Muslim females12), but no objective outcome evaluations 
have been reported as yet. Until a stronger and more specific evidence base is 
available, efforts to promote physical activity among South Asian communities 
should be based on the best available evidence from the general population, applied 
as appropriate within South Asian communities using the principles recommended by 




We do not kn
w
research. Studies are needed to monitor activity and fitness in successive cohorts of 
South Asian children and adults in order to identify emerging trends.  Detailed 
qualitative research will help us to understand better the barriers to and opportunities 
for physical activity, and develop culturally acceptable interventions.  These will then 
need to be tested for efficacy and effectiveness in appropriate outcome evaluations 
within South Asian communities. Developments in practice need to be across a range 
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Poverty, stress and racism as factors in 
South Asian heart disease  
 




Complementary to reviews of physiological and genetic causes of South Asian heart 
disease, we aim to discuss three important social factors, not necessarily to provide an 
alternative explanation, but more probably as a deeper background influence which 
may be affecting a number of physiological pathways.  It is important to recognise 
that the strength of a social influence is not limited to any particular physiological 
pathway with which it is linked, but is usually the sum of various scattered pathways, 
both known and unknown.  This summary will focus on recent research which has 
explicitly sought to link at least one of these social factors with an accepted pathway 
of risk for heart disease. 
 
Research on poverty, stress, and racism as factors in heart disease has had a curious 
development shaped by the political history of the last five decades.  From the 1960s 
to the 1980s, poverty and racism were researched as social issues, primarily in the UK 
and USA. The civil rights movement in the USA, centred on Black Americans, 
roused echoes in the UK as another Anglophone country with a black population in 
deprived circumstances. The research was primarily sociological, and the South Asian 
communities were included only as another group which could fall under a politicised 
Black label.  At the same time research was developing on South Asian heart disease 
as a separate issue, mostly centred in different locations which included the UK, 
Trinidad, Malaysia and South Africa, destinations of South Asian migrants under the 
former British Empire. This research was primarily clinical and epidemiological. 
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The connection between these two lines of research had common geographical 
ground only in the UK, and as a result the question whether poverty, stress and racism 
had a connection with South Asian heart disease was to become primarily a UK 
question. And at first, on the data available in the 1960s to the 1980s, it seemed that it 
was a question destined to be answered “no”.  Taking poverty first, no social class 
gradient was found in South Asian CHD mortality in the first study linking mortality 
with country of birth on data from 1970-781. When consideration moved to stress, the 
principal review of the situation published in 19892 found no evidence of higher 
levels of psychiatric distress in South Asians in the research conducted up to that 
time, mainly in Birmingham. As for racism, the main obstacle to confirming a link 
was the absence of any evidence of excess CHD in the UK Black Caribbean 
population, which was taken to be the paradigmatic case for experience of racism. It 
was soon suggested, though, that there might be different physiological pathways 
which explained the high South Asian CHD rates and the high incidence of stroke in 
Black Caribbeans as responses to the same stressors1.   
 
If there was in fact a connection, therefore, between excess South Asian CHD and 
poverty, stress and racism, it was going to be a matter of penetrating disguises which 
had cloaked this link in preceding data, and the research of the 1990s set out to 
examine this possibility.   
 
The re-emerging social class gradient 
 
The first of these disguises to be penetrated was the absence of a social class gradient 
in South Asian heart disease. Research in the Medical Research Council (MRC) 
Medical Sociology Unit programme indicated that there had been a temporary 
disruption of class chances and standard of living gradients in the South Asian 
population in the period after their migration3. By class chances is meant the link 
between occupational level and standard of living – this was broken because South 
Asians entered the UK labour force at quite different levels to those which they had 
held in the economy of the subcontinent, and had very varying success in re-
establishing a stable connection between their qualifications and their occupational 
level. Many well-educated people sank, and many shrewd and energetic people 
overcame educational deficits to prosper in their own business enterprises. By 
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standard of living gradients is meant the link between standard of living and mortality 
or morbidity – because standard of living was so variable in these conditions, no 
stable connection could be discerned for some decades.   
 
However by 1987 standard of living gradients were re-emerging, at least in CHD risk 
behaviours, though it was likely that this would take time to work through into 
chronic morbidity and mortality3. By 1993/4, standard of living gradients were 
confirmed in South Asian reports of CHD, with more than half of the excess reported 
by Pakistanis and Bangladeshis being accounted for in this way4,5.  In the 1991-3 
mortality data a social class gradient in South Asian CHD had also re-emerged6. 
 
In the last three years, a burst of activity has added detail to these findings.  In the 
Whitehall study of UK civil servants, adjusting for socio-economic grade (probably a 
finer index of standard of living in this setting than social class position) attenuates 
excess biochemical CHD risk in South Asian civil servants, though it does not abolish 
it7.  Similarly in data from the 1991 UK Census with deaths from 1991-3, adjusting 
for social class gradients attenuates, though it does not explain, Pakistani and 
Bangladeshi CHD mortality (until social class position is securely linked with 
standard of living in South Asian families who are self-employed attenuation can be 
expected to be incomplete)8.  A retrospective look at the UK ONS Longitudinal 
Study, which began in 1971, reveals that social class and deprivation gradients began 
to emerge in South Asian mortality generally during the period after 1981 up to 
19979. At a finer-grain level, it appears from the 1993-7 Newcastle study that the 
socio-economic gradient was then strongest in CHD risk behaviours, and in the 
longest-resident subgroup (Indians), and was still uncertain in biochemical measures 
and in other groups10. 
 
Re-assessing stress and racism 
 
Stress is often a vague term, but four quite specific psychosocial determinants of 
CHD have been confirmed in numerous previous prospective cohort studies11:  
1. Anxiety and depression 
2. Hostility and Type A personality 
3. Particular kinds of job strain 
  140 
4. Low social support 
 
These determinants may affect CHD directly or work through health behaviour.  At 
the same time they may themselves be the outcome either of low socio-economic 
position, or of racism.  A resulting model can be formulated as in Figure 12.1. 
 










racism   
health 
behaviour 
         
CHD 
low SES    psychosocial determinants
 
We noted earlier that at first little evidence was found of excess anxiety and 
depression amongst South Asians; hence if excess levels were in fact disguised, the 
question had to be whether there was some form of denial in habitual modes of 
expressing psychological distress.  This possibility was accentuated by research on 
Black Americans in the 1990s.  Blood pressure in this group was found to be higher 
in those who said they had experienced no racism12, or in those claiming least 
experience of racism as well as those claiming most such experience13. It was also 
higher in those who said they would say nothing and do nothing about racist 
incidents. In addition Black Americans had also been found by Dressler during the 
1980s to manifest a characteristic psychosomatic expression of distress14. 
 
Amongst South Asians, the possibility seemed to be that anxiety and depression are 
somatised.  Dressler’s psychosomatic measure was used in the MRC’s 1987 data 
referred to earlier, and was found to be sensitive to experience of poverty, stress in 
work about the house, and experience of assault (including racist assaults), while 
psychological distress as measured by the General Health Questionnaire (GHQ) 
remained insensitive15. The GHQ is a standard, well-attested screening measure of 
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expressed distress in the UK population and many others16. There are indications, 
however, that the language in which distress is expressed is important. Self-assessed 
distress on a very simple verbal measure was just as sensitive to factors affecting the 
psychosomatic measure in the MRC data. South Asian women, Muslims and limited 
English speakers all showed excess distress on these more sensitive measures, and the 
poverty and stress measures were sufficient to explain this distress. At the same time, 
the GHQ is in fact sensitive to South Asian experience of stress in paid work15. In the 
Whitehall study, South Asian civil servants were more depressed than white civil 
servants on this measure17. 
 
Turning to hostility, and the frustrations associated in early research with what was 
called the Type A personality, it has been found that hostility is related to high effort 
and low reward, and this combination in turn predicts CHD18. Recently the Whitehall 
study has shown that South Asian civil servants experience more effort/reward 
imbalance, and have higher hostility levels, than white civil servants17. A link of this 
kind may well underlie the allied finding in the ONS Longitudinal Study that 
downward job mobility predicts a higher risk of limiting longstanding illness in South 
Asians and West Indians than in other members of the study19.  This being so, further 
research is also needed on another characteristic occupational niche of South Asians 
in Britain – the low-income, self-employed situation, where high effort and low 
reward are only too likely concomitants. 
 
Job strain has increasingly been linked with low job control. In the UK civil service, 
South Asians have less job control than whites, and this is explained by the fact that 
they have lower job grades. However, at each job grade, South Asians have higher 
educational qualifications than whites17.   
 
Social support has a number of dimensions, and the picture is usually a balance of 
opposing tendencies. More South Asians of the migrant generation are married than 
the general population of the same age; however more see parents and siblings less 
than once a year, and more South Asian women have no parents or siblings nearby (a 
feature of the patrilocal tendency which constructs households around husbands and 
their fathers). As a result of this combination of familial and migratory patterns, fewer 
South Asian migrants than the general population in Britain say they have “someone 
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to turn to when something is bothering them or they are feeling low”20; and those with 
no one to turn to are more likely to be distressed15. These patterns are likely to change 
in the UK-born generation, where more households are located near the wife’s 
parents. There is also the question of whether social relationships are positive or 
negative for the parties concerned. In the Whitehall study South Asian civil servants 
more often had negative social relationships (though men had more confiding 
support). They also had less social support at work17. 
 
In all four dimensions of psychosocial risk for CHD, therefore, South Asians are now 
emerging as at high risk. The time is at hand to test systematically for the extent to 
which these results are linked with poverty and racism, as in the model set out in 
Figure 12.1. Meanwhile this model can be further expanded to include the question 
whether South Asians with potential CHD-related symptoms are able to get adequate 
health care. 
 
Access of CHD patients to proper health care 
 
Racism is a spectrum of behaviour in which frank, overt, intentional racism is not a 
very common component, at least in the UK. More common is covert antagonistic 
behaviour, or routine behaviour of a kind which puts members of particular cultural 
minorities at a disadvantage because the actor has not thought about possible 
consequences in that context.  An expanded model would acknowledge that poverty 
and racism are both capable of reducing chances of access to good health care, and 
this in turn could affect CHD survival, as in Figure 12.2.   
 







CHD survivalreduced access to health care
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A number of studies suggest that obstacles to care of heart disease which fall under 
the broad heading of racism, as defined above, are in fact occurring.  Back in 1993, 
time from onset of angina symptoms until referral to a regional cardiothoracic centre 
was found to be ten months longer in Indian origin patients than in European patients 
matched for age, sex and extent of coronary disease21. This raises the question 
whether the reason for this is likely to be in the patient’s illness behaviour – the 
interpretation of symptoms, for example – or in the clinician’s response. A 
subsequent study in London found that Hindus and Sikhs actually report greater 
likelihood of seeking immediate care for angina symptoms than Europeans22. This 
placed the onus of investigation on the clinician.  Already in 1989, it had been 
reported that native British patients were more likely to leave their GP surgery with a 





In the matter of whether poverty, stress and racism are contributing to excess South 
Asian heart disease, science has now come full circle.  What seemed an implausible 
hypothesis in the 1960s-1980s now seems, after careful detective work which has 
penetrated many disguises, a hypothesis which is overdue for re-testing.  The model 
developed in Figure 2 provides a basis for research in the first decade of the new 
millennium. This research needs to identify prospective cohorts on a national scale, 
and to integrate the piecemeal advances of the 1990s by systematic tests on all the 
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The high rate of coronary heart disease (CHD) in South Asians has attracted high 
quality research. It is well represented in the chapters of this book. There are at least 
three reasons why research in this area is timely and much needed. First, there is the 
problem itself. To take action to reduce this health burden, proper scientific 
understanding is necessary. Research findings should guide intervention efforts. 
Second, understanding this particular problem has the potential for shedding light on 
areas of the causes of CHD that are imperfectly understood. Examining ethnic 
differences in disease is a way of testing older hypotheses and developing and 
refining new ones. Third, research in this area has much to teach on approaches to 
understanding and researching ethnic differences in disease. 
 
It is, unfortunately, quite common in research to have a great deal of data but few 
ideas. In this area ideas abound; it is the data that are lacking. There are, for example, 
clear hints that CHD rates are higher in urban areas in India than in rural areas, but 
few data that document this clearly or shed light on why it should be the case. 
Similarly, there are interesting suggestions that coronary risk factors are elevated 
among UK South Asian men compared to their brothers in India who did not migrate. 
Systematic investigation of migrants has great potential to illuminate how genetic 
predisposition may interact with environmental and lifestyle changes. There are a 
number of competing explanations for the high rate of CHD in South Asians, but the 
lack of a cohort study of sufficient power to investigate the causes of ethnic variations 
in CHD. 
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In the absence of such data, it is reasonable to assume that risk factors, established as 
such in other populations, will also predict disease in South Asians. Knowing that a 
risk factor is predictive in South Asians does not, by itself, account for the excess 
CHD in South Asians. For example, LDL cholesterol and smoking are lower in some 
South Asian groups than in the general population in England1. We must look 
elsewhere for explanations. 
 
The studies that McKeigue2 and I did pointed to the potential importance of insulin 
and glucose metabolism, the metabolic syndrome, and diabetes. This raised many 
questions. Among them were why lack of exercise and obesity should be more likely 
to lead to central adiposity in South Asians, than in non-Asians. 
 
Diet is an obvious candidate to consider given the differences in average patterns 
between South Asians and others. The picture is far from clear and will require 
further examination. One particular hypothesis is that low intake of folic acid in South 
Asians may account for high levels of plasma homocysteine (see chapter 8 by Sanders 
in this volume). 
 
The role of infection and inflammation in heart disease in general remains to be 
clarified. Here, a crucial issue has to do with confounding; might people exposed to 
infection have been exposed to other adverse environmental conditions? 
 
There is great interest in genetic contributions. These should not be thought of in 
isolation from environmental influences. For example, twin studies show that obesity 
is 60–80% heritable. Yet migrant studies show clear influence of environment. The 
study comparing Indians in West London with their siblings in India showed a mean 
difference in body mass index (BMI) of 4. Assuming no difference in height, this 
corresponds to a mean difference in weight of about 12 kilograms. Putting it 
differently, it is consistent with an interpretation that people move from the 
environment where few are overweight (defined as BMI>25) to one where the 
majority are. The heritability estimates from twin studies understate the contribution 
of the environment where this changes significantly. 
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The early life studies sound several cautionary notes (see chapter 5 by Fall in this 
volume). The high prevalence of low birth weight in India is entirely consistent with 
the prediction of high rates of heart disease in those birth cohorts. The addition of 
obesity in childhood and young adulthood is likely to exacerbate that risk. The 
interaction of influences from early life with circumstance in adulthood will be a 
fertile area for further research that will be crucial in laying a basis for prevention. 
 
My own early studies of immigrants from the Indian subcontinent suggested very 
little social gradient in CHD while much of my other research has pointed to the 
importance of social and psychosocial influences on CHD, which did not seem 
promising as explanations for the high rate of CHD in South Asians3. Williams and 
Harding argue convincingly that it is time to examine these hypotheses again (see 
chapter 12 in this volume). Recent data show that there is an inverse social gradient in 
CHD in South Asians and there may well be an adverse pattern of exposure to 
psychosocial factors4. 
 
Although this collection of papers has focussed on coronary heart disease in South 
Asians there is potentially much to learn from comparisons with other ethnic groups. 
These can potentially shed light on the way that social and biological factors interact 
to cause variation in disease rates. This is an area of research that holds much promise 
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